{"ncbi_accession":["ERR12405917"],"spots":20063658,"bases":6059224716,"biosample":"SAMEA12111288","sra_experiment":"ERX11781968","sra_sample":"ERS9758121","sra_study":"ERP134027","study_name":"GunjurA_2024","sample_id":"GunjurA_2024_9","subject_id":"GunjurA_2024_9","treatments":"Nivolumab,Ipilimumab","age":37,"sex":"Female","country":"Austalia","bmi":20.31,"ecog performance status":1,"subcohort":"GYN","curator":"Alice_Bassetto; Paolo_Manghi","westernized":"Yes","disease_response_recist":"RECIST Progressive Disease","disease_response_pfs_month":79,"disease_response_os_unit":"month","disease_response_os":105,"disease_response_pfs":"No","tumor_size_measurement":45.0,"location":"Melbourne","antibiotics_current_use":"Yes","dna_extraction_kit":"FastDNA","sequencing_platform":"NovaSeq","neutrophil_to_lymphocyte_ratio_measurement":3.0,"(uncurated)platelets":375,"albumin_in_g/dl":3.8,"lactate_dehydrogenase_measurement_in_u/l":178,"concentration":6.82,"number_bases":6059224716,"number_reads":40127316,"minimum_read_length":151,"median_read_length":151.0}
{"ncbi_accession":["ERR12405950"],"spots":23605145,"bases":7128753790,"biosample":"SAMEA12111382","sra_experiment":"ERX11782001","sra_sample":"ERS9758215","sra_study":"ERP134027","study_name":"GunjurA_2024","sample_id":"GunjurA_2024_60","subject_id":"GunjurA_2024_60","treatments":"Nivolumab,Ipilimumab,Proton Pump Inhibitor","age":58,"sex":"Female","country":"Austalia","bmi":25.42,"ecog performance status":1,"subcohort":"UGB","curator":"Alice_Bassetto; Paolo_Manghi","westernized":"Yes","disease_response_recist":"RECIST Progressive Disease","disease_response_pfs_month":65,"disease_response_os_unit":"month","disease_response_os":65,"disease_response_pfs":"No","tumor_size_measurement":64.0,"location":"Albury","antibiotics_current_use":"No","dna_extraction_kit":"FastDNA","sequencing_platform":"NovaSeq","neutrophil_to_lymphocyte_ratio_measurement":5.88,"(uncurated)platelets":575,"albumin_in_g/dl":2.0,"lactate_dehydrogenase_measurement_in_u/l":898,"concentration":14.74,"number_bases":7128753790,"number_reads":47210290,"minimum_read_length":151,"median_read_length":151.0}
{"ncbi_accession":["ERR12405959"],"spots":19959340,"bases":6027720680,"biosample":"SAMEA12111289","sra_experiment":"ERX11782010","sra_sample":"ERS9758122","sra_study":"ERP134027","study_name":"GunjurA_2024","sample_id":"GunjurA_2024_69","subject_id":"GunjurA_2024_69","treatments":"Nivolumab,Ipilimumab,Proton Pump Inhibitor","age":55,"sex":"Male","country":"Austalia","bmi":24.93,"ecog performance status":1,"subcohort":"NEN","curator":"Alice_Bassetto; Paolo_Manghi","westernized":"Yes","disease_response_recist":"RECIST Stable Disease","disease_response_pfs_month":416,"disease_response_os_unit":"month","disease_response_os":867,"disease_response_pfs":"No","tumor_size_measurement":220.0,"location":"Melbourne","antibiotics_current_use":"No","dna_extraction_kit":"FastDNA","sequencing_platform":"NovaSeq","neutrophil_to_lymphocyte_ratio_measurement":7.5,"(uncurated)platelets":319,"albumin_in_g/dl":3.6,"lactate_dehydrogenase_measurement_in_u/l":128,"concentration":378.25,"number_bases":6027720680,"number_reads":39918680,"minimum_read_length":151,"median_read_length":151.0}
{"ncbi_accession":["ERR12405954"],"spots":16893209,"bases":5101749118,"biosample":"SAMEA12111282","sra_experiment":"ERX11782005","sra_sample":"ERS9758115","sra_study":"ERP134027","study_name":"GunjurA_2024","sample_id":"GunjurA_2024_64","subject_id":"GunjurA_2024_64","treatments":"Nivolumab,Ipilimumab,Proton Pump Inhibitor","age":30,"sex":"Female","country":"Austalia","bmi":18.58,"ecog performance status":1,"subcohort":"GYN","curator":"Alice_Bassetto; Paolo_Manghi","westernized":"Yes","disease_response_recist":"RECIST Progressive Disease","disease_response_pfs_month":80,"disease_response_os_unit":"month","disease_response_os":1337,"disease_response_pfs":"No","tumor_size_measurement":131.0,"location":"Melbourne","antibiotics_current_use":"No","dna_extraction_kit":"FastDNA","sequencing_platform":"NovaSeq","neutrophil_to_lymphocyte_ratio_measurement":2.53,"(uncurated)platelets":337,"albumin_in_g/dl":4.1,"lactate_dehydrogenase_measurement_in_u/l":188,"concentration":204.42,"number_bases":5101749118,"number_reads":33786418,"minimum_read_length":151,"median_read_length":151.0}
{"ncbi_accession":["ERR12405914"],"spots":18514290,"bases":5591315580,"biosample":"SAMEA12111369","sra_experiment":"ERX11781965","sra_sample":"ERS9758202","sra_study":"ERP134027","study_name":"GunjurA_2024","sample_id":"GunjurA_2024_6","subject_id":"GunjurA_2024_6","treatments":"Nivolumab,Ipilimumab,Proton Pump Inhibitor","age":46,"sex":"Male","country":"Austalia","bmi":26.08,"ecog performance status":1,"subcohort":"NEN","curator":"Alice_Bassetto; Paolo_Manghi","westernized":"Yes","disease_response_recist":"RECIST Partial Response","disease_response_pfs_month":714,"disease_response_os_unit":"month","disease_response_os":714,"disease_response_pfs":"Yes","tumor_size_measurement":66.0,"location":"Melbourne","antibiotics_current_use":"No","dna_extraction_kit":"FastDNA","sequencing_platform":"NovaSeq","neutrophil_to_lymphocyte_ratio_measurement":3.86,"(uncurated)platelets":152,"albumin_in_g/dl":4.0,"lactate_dehydrogenase_measurement_in_u/l":210,"concentration":86.11,"number_bases":5591315580,"number_reads":37028580,"minimum_read_length":151,"median_read_length":151.0}
{"ncbi_accession":["ERR12405971"],"spots":20502060,"bases":6191622120,"biosample":"SAMEA12111304","sra_experiment":"ERX11782022","sra_sample":"ERS9758136","sra_study":"ERP134027","study_name":"GunjurA_2024","sample_id":"GunjurA_2024_81","subject_id":"GunjurA_2024_81","treatments":"Nivolumab,Ipilimumab,Chemoradiotherapy","age":43,"sex":"Male","country":"Austalia","bmi":30.39,"ecog performance status":0,"subcohort":"UGB","curator":"Alice_Bassetto; Paolo_Manghi","westernized":"Yes","disease_response_recist":"RECIST Stable Disease","disease_response_pfs_month":136,"disease_response_os_unit":"month","disease_response_os":557,"disease_response_pfs":"No","tumor_size_measurement":40.0,"location":"Melbourne","antibiotics_current_use":"No","dna_extraction_kit":"FastDNA","sequencing_platform":"NovaSeq","neutrophil_to_lymphocyte_ratio_measurement":1.76,"(uncurated)platelets":264,"albumin_in_g/dl":4.2,"lactate_dehydrogenase_measurement_in_u/l":219,"concentration":89.8,"number_bases":6191622120,"number_reads":41004120,"minimum_read_length":151,"median_read_length":151.0}
{"ncbi_accession":["ERR12405927"],"spots":19298632,"bases":5828186864,"biosample":"SAMEA12111379","sra_experiment":"ERX11781978","sra_sample":"ERS9758213","sra_study":"ERP134027","study_name":"GunjurA_2024","sample_id":"GunjurA_2024_19","subject_id":"GunjurA_2024_19","treatments":"Nivolumab,Ipilimumab","age":22,"sex":"Female","country":"Austalia","bmi":18.9,"ecog performance status":0,"subcohort":"NEN","curator":"Alice_Bassetto; Paolo_Manghi","westernized":"Yes","disease_response_recist":"RECIST Stable Disease","disease_response_pfs_month":167,"disease_response_os_unit":"month","disease_response_os":287,"disease_response_pfs":"No","tumor_size_measurement":111.0,"location":"Melbourne","antibiotics_current_use":"Yes","dna_extraction_kit":"FastDNA","sequencing_platform":"NovaSeq","neutrophil_to_lymphocyte_ratio_measurement":2.92,"(uncurated)platelets":132,"albumin_in_g/dl":3.2,"lactate_dehydrogenase_measurement_in_u/l":273,"concentration":264.43,"number_bases":5828186864,"number_reads":38597264,"minimum_read_length":151,"median_read_length":151.0}
{"ncbi_accession":["ERR12405969"],"spots":20314532,"bases":6134988664,"biosample":"SAMEA12111299","sra_experiment":"ERX11782020","sra_sample":"ERS9758134","sra_study":"ERP134027","study_name":"GunjurA_2024","sample_id":"GunjurA_2024_79","subject_id":"GunjurA_2024_79","treatments":"Nivolumab,Ipilimumab","age":74,"sex":"Male","country":"Austalia","bmi":19.25,"ecog performance status":1,"subcohort":"UGB","curator":"Alice_Bassetto; Paolo_Manghi","westernized":"Yes","disease_response_recist":"RECIST Progressive Disease","disease_response_pfs_month":14,"disease_response_os_unit":"month","disease_response_os":25,"disease_response_pfs":"No","tumor_size_measurement":108.0,"location":"Melbourne","antibiotics_current_use":"No","dna_extraction_kit":"FastDNA","sequencing_platform":"NovaSeq","neutrophil_to_lymphocyte_ratio_measurement":13.11,"(uncurated)platelets":478,"albumin_in_g/dl":2.5,"lactate_dehydrogenase_measurement_in_u/l":149,"concentration":66.59,"number_bases":6134988664,"number_reads":40629064,"minimum_read_length":151,"median_read_length":151.0}
{"ncbi_accession":["ERR12405978"],"spots":19023226,"bases":5745014252,"biosample":"SAMEA12111310","sra_experiment":"ERX11782029","sra_sample":"ERS9758143","sra_study":"ERP134027","study_name":"GunjurA_2024","sample_id":"GunjurA_2024_88","subject_id":"GunjurA_2024_88","treatments":"Nivolumab,Ipilimumab,Chemoradiotherapy","age":51,"sex":"Male","country":"Austalia","bmi":35.3,"ecog performance status":0,"subcohort":"NEN","curator":"Alice_Bassetto; Paolo_Manghi","westernized":"Yes","disease_response_recist":"RECIST Partial Response","disease_response_pfs_month":1164,"disease_response_os_unit":"month","disease_response_os":1164,"disease_response_pfs":"Yes","tumor_size_measurement":77.0,"location":"Melbourne","antibiotics_current_use":"No","dna_extraction_kit":"FastDNA","sequencing_platform":"NovaSeq","neutrophil_to_lymphocyte_ratio_measurement":1.7,"(uncurated)platelets":219,"albumin_in_g/dl":3.7,"lactate_dehydrogenase_measurement_in_u/l":444,"concentration":49.68,"number_bases":5745014252,"number_reads":38046452,"minimum_read_length":151,"median_read_length":151.0}
{"ncbi_accession":["ERR12405965"],"spots":21284956,"bases":6428056712,"biosample":"SAMEA12111295","sra_experiment":"ERX11782016","sra_sample":"ERS9758129","sra_study":"ERP134027","study_name":"GunjurA_2024","sample_id":"GunjurA_2024_75","subject_id":"GunjurA_2024_75","treatments":"Nivolumab,Ipilimumab,Proton Pump Inhibitor","age":65,"sex":"Female","country":"Austalia","bmi":22.76,"ecog performance status":1,"subcohort":"GYN","curator":"Alice_Bassetto; Paolo_Manghi","westernized":"Yes","disease_response_recist":"RECIST Progressive Disease","disease_response_pfs_month":18,"disease_response_os_unit":"month","disease_response_os":39,"disease_response_pfs":"No","tumor_size_measurement":42.0,"location":"Melbourne","antibiotics_current_use":"No","dna_extraction_kit":"FastDNA","sequencing_platform":"NovaSeq","neutrophil_to_lymphocyte_ratio_measurement":6.88,"(uncurated)platelets":302,"albumin_in_g/dl":3.6,"lactate_dehydrogenase_measurement_in_u/l":807,"concentration":203.54,"number_bases":6428056712,"number_reads":42569912,"minimum_read_length":151,"median_read_length":151.0}
{"ncbi_accession":["ERR12405983"],"spots":19173186,"bases":5790302172,"biosample":"SAMEA12111316","sra_experiment":"ERX11782034","sra_sample":"ERS9758149","sra_study":"ERP134027","study_name":"GunjurA_2024","sample_id":"GunjurA_2024_93","subject_id":"GunjurA_2024_93","treatments":"Nivolumab,Ipilimumab","age":58,"sex":"Male","country":"Austalia","bmi":31.02,"ecog performance status":0,"subcohort":"NEN","curator":"Alice_Bassetto; Paolo_Manghi","westernized":"Yes","disease_response_recist":"RECIST Stable Disease","disease_response_pfs_month":338,"disease_response_os_unit":"month","disease_response_os":645,"disease_response_pfs":"No","tumor_size_measurement":204.0,"location":"Melbourne","antibiotics_current_use":"No","dna_extraction_kit":"FastDNA","sequencing_platform":"NovaSeq","neutrophil_to_lymphocyte_ratio_measurement":1.62,"(uncurated)platelets":167,"albumin_in_g/dl":4.0,"lactate_dehydrogenase_measurement_in_u/l":189,"concentration":41.18,"number_bases":5790302172,"number_reads":38346372,"minimum_read_length":151,"median_read_length":151.0}
{"ncbi_accession":["ERR12405980"],"spots":30980500,"bases":9356111000,"biosample":"SAMEA12111312","sra_experiment":"ERX11782031","sra_sample":"ERS9758145","sra_study":"ERP134027","study_name":"GunjurA_2024","sample_id":"GunjurA_2024_90","subject_id":"GunjurA_2024_90","treatments":"Nivolumab,Ipilimumab","age":72,"sex":"Female","country":"Austalia","bmi":24.61,"ecog performance status":1,"subcohort":"NEN","curator":"Alice_Bassetto; Paolo_Manghi","westernized":"Yes","disease_response_recist":"RECIST Partial Response","disease_response_pfs_month":301,"disease_response_os_unit":"month","disease_response_os":960,"disease_response_pfs":"No","tumor_size_measurement":67.0,"location":"Melbourne","antibiotics_current_use":"No","dna_extraction_kit":"FastDNA","sequencing_platform":"NovaSeq","neutrophil_to_lymphocyte_ratio_measurement":5.62,"(uncurated)platelets":287,"albumin_in_g/dl":3.9,"lactate_dehydrogenase_measurement_in_u/l":1236,"concentration":110.33,"number_bases":9356111000,"number_reads":61961000,"minimum_read_length":151,"median_read_length":151.0}
{"ncbi_accession":["ERR12405960"],"spots":22019672,"bases":6649940944,"biosample":"SAMEA12111290","sra_experiment":"ERX11782011","sra_sample":"ERS9758123","sra_study":"ERP134027","study_name":"GunjurA_2024","sample_id":"GunjurA_2024_70","subject_id":"GunjurA_2024_70","treatments":"Nivolumab,Ipilimumab,Proton Pump Inhibitor","age":76,"sex":"Female","country":"Austalia","bmi":22.77,"ecog performance status":1,"subcohort":"GYN","curator":"Alice_Bassetto; Paolo_Manghi","westernized":"Yes","disease_response_recist":"RECIST Complete Response","disease_response_pfs_month":1295,"disease_response_os_unit":"month","disease_response_os":1295,"disease_response_pfs":"Yes","tumor_size_measurement":81.0,"location":"Melbourne","antibiotics_current_use":"No","dna_extraction_kit":"FastDNA","sequencing_platform":"NovaSeq","neutrophil_to_lymphocyte_ratio_measurement":2.95,"(uncurated)platelets":321,"albumin_in_g/dl":4.0,"lactate_dehydrogenase_measurement_in_u/l":278,"concentration":188.39,"number_bases":6649940944,"number_reads":44039344,"minimum_read_length":151,"median_read_length":151.0}
{"ncbi_accession":["ERR12405956"],"spots":53909635,"bases":16280709770,"biosample":"SAMEA12111285","sra_experiment":"ERX11782007","sra_sample":"ERS9758118","sra_study":"ERP134027","study_name":"GunjurA_2024","sample_id":"GunjurA_2024_66","subject_id":"GunjurA_2024_66","treatments":"Nivolumab,Ipilimumab,Proton Pump Inhibitor","age":38,"sex":"Male","country":"Austalia","bmi":28.19,"ecog performance status":0,"subcohort":"NEN","curator":"Alice_Bassetto; Paolo_Manghi","westernized":"Yes","disease_response_recist":"RECIST Partial Response","disease_response_pfs_month":1413,"disease_response_os_unit":"month","disease_response_os":1413,"disease_response_pfs":"Yes","tumor_size_measurement":62.0,"location":"Melbourne","antibiotics_current_use":"No","dna_extraction_kit":"FastDNA","sequencing_platform":"NovaSeq","neutrophil_to_lymphocyte_ratio_measurement":3.29,"(uncurated)platelets":276,"albumin_in_g/dl":4.1,"lactate_dehydrogenase_measurement_in_u/l":440,"concentration":224.58,"number_bases":16280709770,"number_reads":107819270,"minimum_read_length":151,"median_read_length":151.0}
{"ncbi_accession":["ERR12405919"],"spots":23576315,"bases":7120047130,"biosample":"SAMEA12111374","sra_experiment":"ERX11781970","sra_sample":"ERS9758207","sra_study":"ERP134027","study_name":"GunjurA_2024","sample_id":"GunjurA_2024_11","subject_id":"GunjurA_2024_11","treatments":"Nivolumab,Ipilimumab","age":51,"sex":"Female","country":"Austalia","bmi":36.63,"ecog performance status":1,"subcohort":"GYN","curator":"Alice_Bassetto; Paolo_Manghi","westernized":"Yes","disease_response_recist":"RECIST Progressive Disease","disease_response_pfs_month":77,"disease_response_os_unit":"month","disease_response_os":201,"disease_response_pfs":"No","tumor_size_measurement":113.1,"location":"Melbourne","antibiotics_current_use":"No","dna_extraction_kit":"FastDNA","sequencing_platform":"NovaSeq","neutrophil_to_lymphocyte_ratio_measurement":2.69,"(uncurated)platelets":221,"albumin_in_g/dl":3.2,"lactate_dehydrogenase_measurement_in_u/l":497,"concentration":45.49,"number_bases":7120047130,"number_reads":47152630,"minimum_read_length":151,"median_read_length":151.0}
{"ncbi_accession":["ERR12405988"],"spots":20228260,"bases":6108934520,"biosample":"SAMEA12111323","sra_experiment":"ERX11782039","sra_sample":"ERS9758156","sra_study":"ERP134027","study_name":"GunjurA_2024","sample_id":"GunjurA_2024_98","subject_id":"GunjurA_2024_98","treatments":"Nivolumab,Ipilimumab,Proton Pump Inhibitor,Chemoradiotherapy","age":65,"sex":"Male","country":"Austalia","bmi":29.1,"ecog performance status":1,"subcohort":"UGB","curator":"Alice_Bassetto; Paolo_Manghi","westernized":"Yes","disease_response_recist":"RECIST Progressive Disease","disease_response_pfs_month":32,"disease_response_os_unit":"month","disease_response_os":32,"disease_response_pfs":"No","tumor_size_measurement":155.0,"location":"Melbourne","antibiotics_current_use":"No","dna_extraction_kit":"FastDNA","sequencing_platform":"NovaSeq","neutrophil_to_lymphocyte_ratio_measurement":9.4,"(uncurated)platelets":255,"albumin_in_g/dl":3.2,"lactate_dehydrogenase_measurement_in_u/l":296,"concentration":50.9,"number_bases":6108934520,"number_reads":40456520,"minimum_read_length":151,"median_read_length":151.0}
{"ncbi_accession":["ERR12405932"],"spots":21808969,"bases":6586308638,"biosample":"SAMEA12111337","sra_experiment":"ERX11781983","sra_sample":"ERS9758170","sra_study":"ERP134027","study_name":"GunjurA_2024","sample_id":"GunjurA_2024_25","subject_id":"GunjurA_2024_25","treatments":"Nivolumab,Ipilimumab,Proton Pump Inhibitor","age":64,"sex":"Male","country":"Austalia","bmi":22.95,"ecog performance status":1,"subcohort":"UGB","curator":"Alice_Bassetto; Paolo_Manghi","westernized":"Yes","disease_response_recist":"RECIST Progressive Disease","disease_response_pfs_month":17,"disease_response_os_unit":"month","disease_response_os":17,"disease_response_pfs":"No","tumor_size_measurement":344.0,"location":"Albury","antibiotics_current_use":"No","dna_extraction_kit":"FastDNA","sequencing_platform":"NovaSeq","neutrophil_to_lymphocyte_ratio_measurement":46.17,"(uncurated)platelets":173,"albumin_in_g/dl":2.2,"lactate_dehydrogenase_measurement_in_u/l":496,"concentration":37.47,"number_bases":6586308638,"number_reads":43617938,"minimum_read_length":151,"median_read_length":151.0}
{"ncbi_accession":["ERR12405915"],"spots":19863654,"bases":5998823508,"biosample":"SAMEA12111283","sra_experiment":"ERX11781966","sra_sample":"ERS9758116","sra_study":"ERP134027","study_name":"GunjurA_2024","sample_id":"GunjurA_2024_7","subject_id":"GunjurA_2024_7","treatments":"Nivolumab,Ipilimumab,Proton Pump Inhibitor","age":57,"sex":"Female","country":"Austalia","bmi":30.48,"ecog performance status":1,"subcohort":"NEN","curator":"Alice_Bassetto; Paolo_Manghi","westernized":"Yes","disease_response_recist":"RECIST Complete Response","disease_response_pfs_month":1384,"disease_response_os_unit":"month","disease_response_os":1384,"disease_response_pfs":"Yes","tumor_size_measurement":83.0,"location":"Melbourne","antibiotics_current_use":"No","dna_extraction_kit":"FastDNA","sequencing_platform":"NovaSeq","neutrophil_to_lymphocyte_ratio_measurement":2.69,"(uncurated)platelets":211,"albumin_in_g/dl":3.6,"lactate_dehydrogenase_measurement_in_u/l":202,"concentration":27.92,"number_bases":5998823508,"number_reads":39727308,"minimum_read_length":151,"median_read_length":151.0}
{"ncbi_accession":["ERR12405989"],"spots":18995657,"bases":5736688414,"biosample":"SAMEA12111324","sra_experiment":"ERX11782040","sra_sample":"ERS9758157","sra_study":"ERP134027","study_name":"GunjurA_2024","sample_id":"GunjurA_2024_99","subject_id":"GunjurA_2024_99","treatments":"Nivolumab,Ipilimumab,Proton Pump Inhibitor","age":70,"sex":"Male","country":"Austalia","bmi":29.07,"ecog performance status":0,"subcohort":"UGB","curator":"Alice_Bassetto; Paolo_Manghi","westernized":"Yes","disease_response_recist":"RECIST Progressive Disease","disease_response_pfs_month":5,"disease_response_os_unit":"month","disease_response_os":12,"disease_response_pfs":"No","tumor_size_measurement":178.0,"location":"Melbourne","antibiotics_current_use":"No","dna_extraction_kit":"FastDNA","sequencing_platform":"NovaSeq","neutrophil_to_lymphocyte_ratio_measurement":3.75,"(uncurated)platelets":155,"albumin_in_g/dl":3.7,"lactate_dehydrogenase_measurement_in_u/l":246,"concentration":203.25,"number_bases":5736688414,"number_reads":37991314,"minimum_read_length":151,"median_read_length":151.0}
{"ncbi_accession":["ERR12405964"],"spots":19596658,"bases":5918190716,"biosample":"SAMEA12111294","sra_experiment":"ERX11782015","sra_sample":"ERS9758128","sra_study":"ERP134027","study_name":"GunjurA_2024","sample_id":"GunjurA_2024_74","subject_id":"GunjurA_2024_74","treatments":"Nivolumab,Ipilimumab","age":51,"sex":"Female","country":"Austalia","bmi":20.95,"ecog performance status":1,"subcohort":"GYN","curator":"Alice_Bassetto; Paolo_Manghi","westernized":"Yes","disease_response_recist":"RECIST Progressive Disease","disease_response_pfs_month":73,"disease_response_os_unit":"month","disease_response_os":77,"disease_response_pfs":"No","tumor_size_measurement":32.0,"location":"Melbourne","antibiotics_current_use":"No","dna_extraction_kit":"FastDNA","sequencing_platform":"NovaSeq","neutrophil_to_lymphocyte_ratio_measurement":2.3,"(uncurated)platelets":603,"albumin_in_g/dl":2.1,"lactate_dehydrogenase_measurement_in_u/l":288,"concentration":336.9,"number_bases":5918190716,"number_reads":39193316,"minimum_read_length":151,"median_read_length":151.0}
{"ncbi_accession":["ERR12405970"],"spots":21118963,"bases":6377926826,"biosample":"SAMEA12111302","sra_experiment":"ERX11782021","sra_sample":"ERS9758135","sra_study":"ERP134027","study_name":"GunjurA_2024","sample_id":"GunjurA_2024_80","subject_id":"GunjurA_2024_80","treatments":"Nivolumab,Ipilimumab","age":58,"sex":"Female","country":"Austalia","bmi":26.41,"ecog performance status":0,"subcohort":"UGB","curator":"Alice_Bassetto; Paolo_Manghi","westernized":"Yes","disease_response_recist":"RECIST Partial Response","disease_response_pfs_month":210,"disease_response_os_unit":"month","disease_response_os":1232,"disease_response_pfs":"No","tumor_size_measurement":46.0,"location":"Melbourne","antibiotics_current_use":"No","dna_extraction_kit":"FastDNA","sequencing_platform":"NovaSeq","neutrophil_to_lymphocyte_ratio_measurement":1.0,"(uncurated)platelets":382,"albumin_in_g/dl":3.0,"lactate_dehydrogenase_measurement_in_u/l":188,"concentration":95.3,"number_bases":6377926826,"number_reads":42237926,"minimum_read_length":151,"median_read_length":151.0}
{"ncbi_accession":["ERR12405913"],"spots":18819673,"bases":5683541246,"biosample":"SAMEA12111279","sra_experiment":"ERX11781964","sra_sample":"ERS9758112","sra_study":"ERP134027","study_name":"GunjurA_2024","sample_id":"GunjurA_2024_5","subject_id":"GunjurA_2024_5","treatments":"Nivolumab,Ipilimumab","age":59,"sex":"Male","country":"Austalia","bmi":24.49,"ecog performance status":1,"subcohort":"UGB","curator":"Alice_Bassetto; Paolo_Manghi","westernized":"Yes","disease_response_recist":"RECIST Progressive Disease","disease_response_pfs_month":31,"disease_response_os_unit":"month","disease_response_os":54,"disease_response_pfs":"No","tumor_size_measurement":198.0,"location":"Melbourne","antibiotics_current_use":"No","dna_extraction_kit":"FastDNA","sequencing_platform":"NovaSeq","neutrophil_to_lymphocyte_ratio_measurement":4.83,"(uncurated)platelets":322,"albumin_in_g/dl":3.7,"lactate_dehydrogenase_measurement_in_u/l":281,"concentration":25.17,"number_bases":5683541246,"number_reads":37639346,"minimum_read_length":151,"median_read_length":151.0}
{"ncbi_accession":["ERR12405963"],"spots":22884955,"bases":6911256410,"biosample":"SAMEA12111296","sra_experiment":"ERX11782014","sra_sample":"ERS9758127","sra_study":"ERP134027","study_name":"GunjurA_2024","sample_id":"GunjurA_2024_73","subject_id":"GunjurA_2024_73","treatments":"Nivolumab,Ipilimumab","age":60,"sex":"Female","country":"Austalia","bmi":32.3,"ecog performance status":0,"subcohort":"GYN","curator":"Alice_Bassetto; Paolo_Manghi","westernized":"Yes","disease_response_recist":"RECIST Stable Disease","disease_response_pfs_month":74,"disease_response_os_unit":"month","disease_response_os":807,"disease_response_pfs":"No","tumor_size_measurement":43.0,"location":"Melbourne","antibiotics_current_use":"No","dna_extraction_kit":"FastDNA","sequencing_platform":"NovaSeq","neutrophil_to_lymphocyte_ratio_measurement":1.12,"(uncurated)platelets":294,"albumin_in_g/dl":3.5,"lactate_dehydrogenase_measurement_in_u/l":155,"concentration":204.28,"number_bases":6911256410,"number_reads":45769910,"minimum_read_length":151,"median_read_length":151.0}
{"ncbi_accession":["ERR12406001"],"spots":19100061,"bases":5768218422,"biosample":"SAMEA12303387","sra_experiment":"ERX11782052","sra_sample":"ERS9910243","sra_study":"ERP134027","study_name":"GunjurA_2024","sample_id":"GunjurA_2024_111","subject_id":"GunjurA_2024_111","treatments":"Nivolumab,Ipilimumab,Proton Pump Inhibitor,Chemoradiotherapy","age":75,"sex":"Female","country":"Austalia","bmi":28.38,"ecog performance status":1,"subcohort":"UGB","curator":"Alice_Bassetto; Paolo_Manghi","westernized":"Yes","disease_response_recist":"RECIST Progressive Disease","disease_response_pfs_month":78,"disease_response_os_unit":"month","disease_response_os":159,"disease_response_pfs":"No","tumor_size_measurement":100.0,"location":"Sydney","antibiotics_current_use":"No","dna_extraction_kit":"FastDNA","sequencing_platform":"NovaSeq","neutrophil_to_lymphocyte_ratio_measurement":2.81,"(uncurated)platelets":240,"albumin_in_g/dl":3.4,"lactate_dehydrogenase_measurement_in_u/l":471,"concentration":124.11,"number_bases":5768218422,"number_reads":38200122,"minimum_read_length":151,"median_read_length":151.0}
{"ncbi_accession":["ERR12405999"],"spots":22045926,"bases":6657869652,"biosample":"SAMEA12111342","sra_experiment":"ERX11782050","sra_sample":"ERS9758174","sra_study":"ERP134027","study_name":"GunjurA_2024","sample_id":"GunjurA_2024_109","subject_id":"GunjurA_2024_109","treatments":"Nivolumab,Ipilimumab,Proton Pump Inhibitor","age":67,"sex":"Female","country":"Austalia","bmi":28.69,"ecog performance status":0,"subcohort":"UGB","curator":"Alice_Bassetto; Paolo_Manghi","westernized":"Yes","disease_response_recist":"RECIST Progressive Disease","disease_response_pfs_month":77,"disease_response_os_unit":"month","disease_response_os":469,"disease_response_pfs":"No","tumor_size_measurement":28.0,"location":"Melbourne","antibiotics_current_use":"No","dna_extraction_kit":"FastDNA","sequencing_platform":"NovaSeq","neutrophil_to_lymphocyte_ratio_measurement":1.89,"(uncurated)platelets":287,"albumin_in_g/dl":3.8,"lactate_dehydrogenase_measurement_in_u/l":162,"concentration":70.14,"number_bases":6657869652,"number_reads":44091852,"minimum_read_length":151,"median_read_length":151.0}
{"ncbi_accession":["ERR12405985"],"spots":21055879,"bases":6358875458,"biosample":"SAMEA12111318","sra_experiment":"ERX11782036","sra_sample":"ERS9758151","sra_study":"ERP134027","study_name":"GunjurA_2024","sample_id":"GunjurA_2024_95","subject_id":"GunjurA_2024_95","treatments":"Nivolumab,Ipilimumab","age":49,"sex":"Female","country":"Austalia","bmi":29.07,"ecog performance status":1,"subcohort":"GYN","curator":"Alice_Bassetto; Paolo_Manghi","westernized":"Yes","disease_response_recist":"RECIST Partial Response","disease_response_pfs_month":560,"disease_response_os_unit":"month","disease_response_os":1090,"disease_response_pfs":"No","tumor_size_measurement":325.0,"location":"Melbourne","antibiotics_current_use":"No","dna_extraction_kit":"FastDNA","sequencing_platform":"NovaSeq","neutrophil_to_lymphocyte_ratio_measurement":3.25,"(uncurated)platelets":299,"albumin_in_g/dl":3.9,"lactate_dehydrogenase_measurement_in_u/l":308,"concentration":75.1,"number_bases":6358875458,"number_reads":42111758,"minimum_read_length":151,"median_read_length":151.0}
{"ncbi_accession":["ERR12405923"],"spots":22915396,"bases":6920449592,"biosample":"SAMEA12111378","sra_experiment":"ERX11781974","sra_sample":"ERS9758211","sra_study":"ERP134027","study_name":"GunjurA_2024","sample_id":"GunjurA_2024_15","subject_id":"GunjurA_2024_15","treatments":"Nivolumab,Ipilimumab,Chemoradiotherapy","age":35,"sex":"Male","country":"Austalia","bmi":23.99,"ecog performance status":0,"subcohort":"NEN","curator":"Alice_Bassetto; Paolo_Manghi","westernized":"Yes","disease_response_recist":"RECIST Stable Disease","disease_response_pfs_month":83,"disease_response_os_unit":"month","disease_response_os":672,"disease_response_pfs":"No","tumor_size_measurement":84.0,"location":"Melbourne","antibiotics_current_use":"No","dna_extraction_kit":"FastDNA","sequencing_platform":"NovaSeq","neutrophil_to_lymphocyte_ratio_measurement":1.18,"(uncurated)platelets":143,"albumin_in_g/dl":3.5,"lactate_dehydrogenase_measurement_in_u/l":178,"concentration":49.04,"number_bases":6920449592,"number_reads":45830792,"minimum_read_length":151,"median_read_length":151.0}
{"ncbi_accession":["ERR12405991"],"spots":26914698,"bases":8128238796,"biosample":"SAMEA12111326","sra_experiment":"ERX11782042","sra_sample":"ERS9758159","sra_study":"ERP134027","study_name":"GunjurA_2024","sample_id":"GunjurA_2024_101","subject_id":"GunjurA_2024_101","treatments":"Nivolumab,Ipilimumab,Chemoradiotherapy","age":67,"sex":"Male","country":"Austalia","bmi":29.48,"ecog performance status":0,"subcohort":"UGB","curator":"Alice_Bassetto; Paolo_Manghi","westernized":"Yes","disease_response_recist":"RECIST Progressive Disease","disease_response_pfs_month":84,"disease_response_os_unit":"month","disease_response_os":204,"disease_response_pfs":"No","tumor_size_measurement":59.0,"location":"Melbourne","antibiotics_current_use":"No","dna_extraction_kit":"FastDNA","sequencing_platform":"NovaSeq","neutrophil_to_lymphocyte_ratio_measurement":1.08,"(uncurated)platelets":215,"albumin_in_g/dl":3.8,"lactate_dehydrogenase_measurement_in_u/l":205,"concentration":88.85,"number_bases":8128238796,"number_reads":53829396,"minimum_read_length":151,"median_read_length":151.0}
{"ncbi_accession":["ERR12405921"],"spots":20449796,"bases":6175838392,"biosample":"SAMEA12111298","sra_experiment":"ERX11781972","sra_sample":"ERS9758133","sra_study":"ERP134027","study_name":"GunjurA_2024","sample_id":"GunjurA_2024_13","subject_id":"GunjurA_2024_13","treatments":"Nivolumab,Ipilimumab","age":57,"sex":"Female","country":"Austalia","bmi":32.33,"ecog performance status":0,"subcohort":"GYN","curator":"Alice_Bassetto; Paolo_Manghi","westernized":"Yes","disease_response_recist":"RECIST Stable Disease","disease_response_pfs_month":210,"disease_response_os_unit":"month","disease_response_os":534,"disease_response_pfs":"No","tumor_size_measurement":37.0,"location":"Melbourne","antibiotics_current_use":"No","dna_extraction_kit":"FastDNA","sequencing_platform":"NovaSeq","neutrophil_to_lymphocyte_ratio_measurement":3.33,"(uncurated)platelets":151,"albumin_in_g/dl":3.8,"lactate_dehydrogenase_measurement_in_u/l":199,"concentration":10.25,"number_bases":6175838392,"number_reads":40899592,"minimum_read_length":151,"median_read_length":151.0}
{"ncbi_accession":["ERR12405973"],"spots":22094096,"bases":6672416992,"biosample":"SAMEA12111305","sra_experiment":"ERX11782024","sra_sample":"ERS9758138","sra_study":"ERP134027","study_name":"GunjurA_2024","sample_id":"GunjurA_2024_83","subject_id":"GunjurA_2024_83","treatments":"Nivolumab,Ipilimumab","age":63,"sex":"Male","country":"Austalia","bmi":22.64,"ecog performance status":1,"subcohort":"UGB","curator":"Alice_Bassetto; Paolo_Manghi","westernized":"Yes","disease_response_recist":"RECIST Partial Response","disease_response_pfs_month":524,"disease_response_os_unit":"month","disease_response_os":582,"disease_response_pfs":"No","tumor_size_measurement":42.0,"location":"Melbourne","antibiotics_current_use":"No","dna_extraction_kit":"FastDNA","sequencing_platform":"NovaSeq","neutrophil_to_lymphocyte_ratio_measurement":4.43,"(uncurated)platelets":144,"albumin_in_g/dl":3.5,"lactate_dehydrogenase_measurement_in_u/l":308,"concentration":78.05,"number_bases":6672416992,"number_reads":44188192,"minimum_read_length":151,"median_read_length":151.0}
{"ncbi_accession":["ERR12405981"],"spots":18541730,"bases":5599602460,"biosample":"SAMEA12111314","sra_experiment":"ERX11782032","sra_sample":"ERS9758147","sra_study":"ERP134027","study_name":"GunjurA_2024","sample_id":"GunjurA_2024_91","subject_id":"GunjurA_2024_91","treatments":"Nivolumab,Ipilimumab,Chemoradiotherapy","age":70,"sex":"Female","country":"Austalia","bmi":23.42,"ecog performance status":0,"subcohort":"NEN","curator":"Alice_Bassetto; Paolo_Manghi","westernized":"Yes","disease_response_recist":"RECIST Complete Response","disease_response_pfs_month":1213,"disease_response_os_unit":"month","disease_response_os":1213,"disease_response_pfs":"Yes","tumor_size_measurement":74.0,"location":"Melbourne","antibiotics_current_use":"No","dna_extraction_kit":"FastDNA","sequencing_platform":"NovaSeq","neutrophil_to_lymphocyte_ratio_measurement":2.71,"(uncurated)platelets":287,"albumin_in_g/dl":3.7,"lactate_dehydrogenase_measurement_in_u/l":311,"concentration":103.81,"number_bases":5599602460,"number_reads":37083460,"minimum_read_length":151,"median_read_length":151.0}
{"ncbi_accession":["ERR12405943"],"spots":28049468,"bases":8470939336,"biosample":"SAMEA12111362","sra_experiment":"ERX11781994","sra_sample":"ERS9758195","sra_study":"ERP134027","study_name":"GunjurA_2024","sample_id":"GunjurA_2024_47","subject_id":"GunjurA_2024_47","treatments":"Nivolumab,Ipilimumab","age":71,"sex":"Female","country":"Austalia","bmi":30.0,"ecog performance status":1,"subcohort":"GYN","curator":"Alice_Bassetto; Paolo_Manghi","westernized":"Yes","disease_response_recist":"RECIST Stable Disease","disease_response_pfs_month":369,"disease_response_os_unit":"month","disease_response_os":436,"disease_response_pfs":"No","tumor_size_measurement":52.0,"location":"Melbourne","antibiotics_current_use":"No","dna_extraction_kit":"FastDNA","sequencing_platform":"NovaSeq","neutrophil_to_lymphocyte_ratio_measurement":3.1,"(uncurated)platelets":430,"albumin_in_g/dl":3.2,"lactate_dehydrogenase_measurement_in_u/l":327,"concentration":32.96,"number_bases":8470939336,"number_reads":56098936,"minimum_read_length":151,"median_read_length":151.0}
{"ncbi_accession":["ERR12405986"],"spots":17067771,"bases":5154466842,"biosample":"SAMEA12111320","sra_experiment":"ERX11782037","sra_sample":"ERS9758154","sra_study":"ERP134027","study_name":"GunjurA_2024","sample_id":"GunjurA_2024_96","subject_id":"GunjurA_2024_96","treatments":"Nivolumab,Ipilimumab","age":38,"sex":"Female","country":"Austalia","bmi":32.35,"ecog performance status":0,"subcohort":"NEN","curator":"Alice_Bassetto; Paolo_Manghi","westernized":"Yes","disease_response_recist":"RECIST Progressive Disease","disease_response_pfs_month":66,"disease_response_os_unit":"month","disease_response_os":73,"disease_response_pfs":"No","tumor_size_measurement":150.0,"location":"Melbourne","antibiotics_current_use":"No","dna_extraction_kit":"FastDNA","sequencing_platform":"NovaSeq","neutrophil_to_lymphocyte_ratio_measurement":3.12,"(uncurated)platelets":264,"albumin_in_g/dl":3.8,"lactate_dehydrogenase_measurement_in_u/l":945,"concentration":80.54,"number_bases":5154466842,"number_reads":34135542,"minimum_read_length":151,"median_read_length":151.0}
{"ncbi_accession":["ERR12405953"],"spots":19742949,"bases":5962370598,"biosample":"SAMEA12111281","sra_experiment":"ERX11782004","sra_sample":"ERS9758114","sra_study":"ERP134027","study_name":"GunjurA_2024","sample_id":"GunjurA_2024_63","subject_id":"GunjurA_2024_63","treatments":"Nivolumab,Ipilimumab,Chemoradiotherapy","age":37,"sex":"Female","country":"Austalia","bmi":23.36,"ecog performance status":0,"subcohort":"NEN","curator":"Alice_Bassetto; Paolo_Manghi","westernized":"Yes","disease_response_recist":"RECIST Progressive Disease","disease_response_pfs_month":75,"disease_response_os_unit":"month","disease_response_os":414,"disease_response_pfs":"No","tumor_size_measurement":26.0,"location":"Melbourne","antibiotics_current_use":"No","dna_extraction_kit":"FastDNA","sequencing_platform":"NovaSeq","neutrophil_to_lymphocyte_ratio_measurement":3.79,"(uncurated)platelets":284,"albumin_in_g/dl":3.7,"lactate_dehydrogenase_measurement_in_u/l":502,"concentration":216.12,"number_bases":5962370598,"number_reads":39485898,"minimum_read_length":151,"median_read_length":151.0}
{"ncbi_accession":["ERR12405990"],"spots":23773728,"bases":7179665856,"biosample":"SAMEA12111325","sra_experiment":"ERX11782041","sra_sample":"ERS9758158","sra_study":"ERP134027","study_name":"GunjurA_2024","sample_id":"GunjurA_2024_100","subject_id":"GunjurA_2024_100","treatments":"Nivolumab,Ipilimumab","age":63,"sex":"Female","country":"Austalia","bmi":36.11,"ecog performance status":0,"subcohort":"GYN","curator":"Alice_Bassetto; Paolo_Manghi","westernized":"Yes","disease_response_recist":"RECIST Stable Disease","disease_response_pfs_month":213,"disease_response_os_unit":"month","disease_response_os":797,"disease_response_pfs":"No","tumor_size_measurement":83.0,"location":"Melbourne","antibiotics_current_use":"No","dna_extraction_kit":"FastDNA","sequencing_platform":"NovaSeq","neutrophil_to_lymphocyte_ratio_measurement":2.44,"(uncurated)platelets":267,"albumin_in_g/dl":3.7,"lactate_dehydrogenase_measurement_in_u/l":219,"concentration":69.56,"number_bases":7179665856,"number_reads":47547456,"minimum_read_length":151,"median_read_length":151.0}
{"ncbi_accession":["ERR12406015"],"spots":23664328,"bases":7146627056,"biosample":"SAMEA12111366","sra_experiment":"ERX11782066","sra_sample":"ERS9758199","sra_study":"ERP134027","study_name":"GunjurA_2024","sample_id":"GunjurA_2024_125","subject_id":"GunjurA_2024_125","treatments":"Nivolumab,Ipilimumab,Proton Pump Inhibitor,Chemoradiotherapy","age":47,"sex":"Female","country":"Austalia","bmi":27.73,"ecog performance status":1,"subcohort":"GYN","curator":"Alice_Bassetto; Paolo_Manghi","westernized":"Yes","disease_response_recist":"RECIST Progressive Disease","disease_response_pfs_month":63,"disease_response_os_unit":"month","disease_response_os":114,"disease_response_pfs":"No","tumor_size_measurement":17.0,"location":"Melbourne","antibiotics_current_use":"No","dna_extraction_kit":"FastDNA","sequencing_platform":"NovaSeq","neutrophil_to_lymphocyte_ratio_measurement":3.95,"(uncurated)platelets":231,"albumin_in_g/dl":3.0,"lactate_dehydrogenase_measurement_in_u/l":229,"concentration":162.43,"number_bases":7146627056,"number_reads":47328656,"minimum_read_length":151,"median_read_length":151.0}
{"ncbi_accession":["ERR12405922"],"spots":20380404,"bases":6154882008,"biosample":"SAMEA12303386","sra_experiment":"ERX11781973","sra_sample":"ERS9910244","sra_study":"ERP134027","study_name":"GunjurA_2024","sample_id":"GunjurA_2024_14","subject_id":"GunjurA_2024_14","treatments":"Nivolumab,Ipilimumab,Proton Pump Inhibitor,Chemoradiotherapy","age":60,"sex":"Male","country":"Austalia","bmi":25.86,"ecog performance status":0,"subcohort":"NEN","curator":"Alice_Bassetto; Paolo_Manghi","westernized":"Yes","disease_response_recist":"RECIST Stable Disease","disease_response_pfs_month":291,"disease_response_os_unit":"month","disease_response_os":665,"disease_response_pfs":"No","tumor_size_measurement":38.0,"location":"Melbourne","antibiotics_current_use":"No","dna_extraction_kit":"FastDNA","sequencing_platform":"NovaSeq","neutrophil_to_lymphocyte_ratio_measurement":2.25,"(uncurated)platelets":121,"albumin_in_g/dl":3.8,"lactate_dehydrogenase_measurement_in_u/l":226,"concentration":149.7,"number_bases":6154882008,"number_reads":40760808,"minimum_read_length":151,"median_read_length":151.0}
{"ncbi_accession":["ERR12405996"],"spots":20741472,"bases":6263924544,"biosample":"SAMEA12111331","sra_experiment":"ERX11782047","sra_sample":"ERS9758165","sra_study":"ERP134027","study_name":"GunjurA_2024","sample_id":"GunjurA_2024_106","subject_id":"GunjurA_2024_106","treatments":"Nivolumab,Ipilimumab","age":26,"sex":"Female","country":"Austalia","bmi":32.28,"ecog performance status":0,"subcohort":"GYN","curator":"Alice_Bassetto; Paolo_Manghi","westernized":"Yes","disease_response_recist":"RECIST Progressive Disease","disease_response_pfs_month":41,"disease_response_os_unit":"month","disease_response_os":173,"disease_response_pfs":"No","tumor_size_measurement":219.0,"location":"Sydney","antibiotics_current_use":"No","dna_extraction_kit":"FastDNA","sequencing_platform":"NovaSeq","neutrophil_to_lymphocyte_ratio_measurement":2.22,"(uncurated)platelets":317,"albumin_in_g/dl":3.7,"lactate_dehydrogenase_measurement_in_u/l":203,"concentration":89.25,"number_bases":6263924544,"number_reads":41482944,"minimum_read_length":151,"median_read_length":151.0}
{"ncbi_accession":["ERR12406006"],"spots":18201895,"bases":5496972290,"biosample":"SAMEA12111352","sra_experiment":"ERX11782057","sra_sample":"ERS9758185","sra_study":"ERP134027","study_name":"GunjurA_2024","sample_id":"GunjurA_2024_116","subject_id":"GunjurA_2024_116","treatments":"Nivolumab,Ipilimumab","age":40,"sex":"Female","country":"Austalia","bmi":21.33,"ecog performance status":0,"subcohort":"NEN","curator":"Alice_Bassetto; Paolo_Manghi","westernized":"Yes","disease_response_recist":"RECIST Progressive Disease","disease_response_pfs_month":83,"disease_response_os_unit":"month","disease_response_os":749,"disease_response_pfs":"No","tumor_size_measurement":75.0,"location":"Sydney","antibiotics_current_use":"No","dna_extraction_kit":"FastDNA","sequencing_platform":"NovaSeq","neutrophil_to_lymphocyte_ratio_measurement":2.0,"(uncurated)platelets":353,"albumin_in_g/dl":4.4,"lactate_dehydrogenase_measurement_in_u/l":177,"concentration":57.1,"number_bases":5496972290,"number_reads":36403790,"minimum_read_length":151,"median_read_length":151.0}
{"ncbi_accession":["ERR12405997"],"spots":21667588,"bases":6543611576,"biosample":"SAMEA12111333","sra_experiment":"ERX11782048","sra_sample":"ERS9758166","sra_study":"ERP134027","study_name":"GunjurA_2024","sample_id":"GunjurA_2024_107","subject_id":"GunjurA_2024_107","treatments":"Nivolumab,Ipilimumab,Chemoradiotherapy","age":40,"sex":"Female","country":"Austalia","bmi":18.78,"ecog performance status":1,"subcohort":"UGB","curator":"Alice_Bassetto; Paolo_Manghi","westernized":"Yes","disease_response_recist":"RECIST Partial Response","disease_response_pfs_month":133,"disease_response_os_unit":"month","disease_response_os":469,"disease_response_pfs":"No","tumor_size_measurement":73.0,"location":"Albury","antibiotics_current_use":"No","dna_extraction_kit":"FastDNA","sequencing_platform":"NovaSeq","neutrophil_to_lymphocyte_ratio_measurement":1.69,"(uncurated)platelets":159,"albumin_in_g/dl":3.8,"lactate_dehydrogenase_measurement_in_u/l":362,"concentration":100.13,"number_bases":6543611576,"number_reads":43335176,"minimum_read_length":151,"median_read_length":151.0}
{"ncbi_accession":["ERR12405926"],"spots":20862067,"bases":6300344234,"biosample":"SAMEA12111380","sra_experiment":"ERX11781977","sra_sample":"ERS9758212","sra_study":"ERP134027","study_name":"GunjurA_2024","sample_id":"GunjurA_2024_18","subject_id":"GunjurA_2024_18","treatments":"Nivolumab,Ipilimumab,Proton Pump Inhibitor,Chemoradiotherapy","age":64,"sex":"Male","country":"Austalia","bmi":31.67,"ecog performance status":1,"subcohort":"UGB","curator":"Alice_Bassetto; Paolo_Manghi","westernized":"Yes","disease_response_recist":"RECIST Progressive Disease","disease_response_pfs_month":87,"disease_response_os_unit":"month","disease_response_os":98,"disease_response_pfs":"No","tumor_size_measurement":138.0,"location":"Melbourne","antibiotics_current_use":"No","dna_extraction_kit":"FastDNA","sequencing_platform":"NovaSeq","neutrophil_to_lymphocyte_ratio_measurement":4.24,"(uncurated)platelets":278,"albumin_in_g/dl":3.6,"lactate_dehydrogenase_measurement_in_u/l":218,"concentration":93.56,"number_bases":6300344234,"number_reads":41724134,"minimum_read_length":151,"median_read_length":151.0}
{"ncbi_accession":["ERR12405984"],"spots":17203241,"bases":5195378782,"biosample":"SAMEA12111317","sra_experiment":"ERX11782035","sra_sample":"ERS9758150","sra_study":"ERP134027","study_name":"GunjurA_2024","sample_id":"GunjurA_2024_94","subject_id":"GunjurA_2024_94","treatments":"Nivolumab,Ipilimumab","age":71,"sex":"Female","country":"Austalia","bmi":22.67,"ecog performance status":1,"subcohort":"GYN","curator":"Alice_Bassetto; Paolo_Manghi","westernized":"Yes","disease_response_recist":"RECIST Partial Response","disease_response_pfs_month":153,"disease_response_os_unit":"month","disease_response_os":473,"disease_response_pfs":"No","tumor_size_measurement":32.0,"location":"Melbourne","antibiotics_current_use":"No","dna_extraction_kit":"FastDNA","sequencing_platform":"NovaSeq","neutrophil_to_lymphocyte_ratio_measurement":7.4,"(uncurated)platelets":190,"albumin_in_g/dl":3.1,"lactate_dehydrogenase_measurement_in_u/l":463,"concentration":45.8,"number_bases":5195378782,"number_reads":34406482,"minimum_read_length":151,"median_read_length":151.0}
{"ncbi_accession":["ERR12405992"],"spots":20656921,"bases":6238390142,"biosample":"SAMEA12111328","sra_experiment":"ERX11782043","sra_sample":"ERS9758161","sra_study":"ERP134027","study_name":"GunjurA_2024","sample_id":"GunjurA_2024_102","subject_id":"GunjurA_2024_102","treatments":"Nivolumab,Ipilimumab","age":72,"sex":"Female","country":"Austalia","bmi":33.25,"ecog performance status":1,"subcohort":"UGB","curator":"Alice_Bassetto; Paolo_Manghi","westernized":"Yes","disease_response_recist":"RECIST Partial Response","disease_response_pfs_month":1009,"disease_response_os_unit":"month","disease_response_os":1009,"disease_response_pfs":"Yes","tumor_size_measurement":49.0,"location":"Melbourne","antibiotics_current_use":"No","dna_extraction_kit":"FastDNA","sequencing_platform":"NovaSeq","neutrophil_to_lymphocyte_ratio_measurement":1.48,"(uncurated)platelets":275,"albumin_in_g/dl":3.2,"lactate_dehydrogenase_measurement_in_u/l":252,"concentration":42.15,"number_bases":6238390142,"number_reads":41313842,"minimum_read_length":151,"median_read_length":151.0}
{"ncbi_accession":["ERR12405929"],"spots":23278615,"bases":7030141730,"biosample":"SAMEA12111334","sra_experiment":"ERX11781980","sra_sample":"ERS9758167","sra_study":"ERP134027","study_name":"GunjurA_2024","sample_id":"GunjurA_2024_21","subject_id":"GunjurA_2024_21","treatments":"Nivolumab,Ipilimumab,Proton Pump Inhibitor,Chemoradiotherapy","age":50,"sex":"Female","country":"Austalia","bmi":21.77,"ecog performance status":1,"subcohort":"UGB","curator":"Alice_Bassetto; Paolo_Manghi","westernized":"Yes","disease_response_recist":"RECIST Progressive Disease","disease_response_pfs_month":80,"disease_response_os_unit":"month","disease_response_os":163,"disease_response_pfs":"No","tumor_size_measurement":68.0,"location":"Melbourne","antibiotics_current_use":"No","dna_extraction_kit":"FastDNA","sequencing_platform":"NovaSeq","neutrophil_to_lymphocyte_ratio_measurement":5.0,"(uncurated)platelets":268,"albumin_in_g/dl":2.9,"lactate_dehydrogenase_measurement_in_u/l":353,"concentration":16.33,"number_bases":7030141730,"number_reads":46557230,"minimum_read_length":151,"median_read_length":151.0}
{"ncbi_accession":["ERR12405911"],"spots":20030906,"bases":6049333612,"biosample":"SAMEA12111278","sra_experiment":"ERX11781962","sra_sample":"ERS9758111","sra_study":"ERP134027","study_name":"GunjurA_2024","sample_id":"GunjurA_2024_3","subject_id":"GunjurA_2024_3","treatments":"Nivolumab,Ipilimumab","age":37,"sex":"Male","country":"Austalia","bmi":32.2,"ecog performance status":0,"subcohort":"NEN","curator":"Alice_Bassetto; Paolo_Manghi","westernized":"Yes","disease_response_recist":"RECIST Stable Disease","disease_response_pfs_month":76,"disease_response_os_unit":"month","disease_response_os":550,"disease_response_pfs":"No","tumor_size_measurement":125.0,"location":"Melbourne","antibiotics_current_use":"No","dna_extraction_kit":"FastDNA","sequencing_platform":"NovaSeq","neutrophil_to_lymphocyte_ratio_measurement":2.87,"(uncurated)platelets":196,"albumin_in_g/dl":3.7,"lactate_dehydrogenase_measurement_in_u/l":337,"concentration":32.74,"number_bases":6049333612,"number_reads":40061812,"minimum_read_length":151,"median_read_length":151.0}
{"ncbi_accession":["ERR12405948"],"spots":19242533,"bases":5811244966,"biosample":"SAMEA12111376","sra_experiment":"ERX11781999","sra_sample":"ERS9758208","sra_study":"ERP134027","study_name":"GunjurA_2024","sample_id":"GunjurA_2024_58","subject_id":"GunjurA_2024_58","treatments":"Nivolumab,Ipilimumab,Proton Pump Inhibitor","age":80,"sex":"Female","country":"Austalia","bmi":25.63,"ecog performance status":0,"subcohort":"NEN","curator":"Alice_Bassetto; Paolo_Manghi","westernized":"Yes","disease_response_recist":"RECIST Stable Disease","disease_response_pfs_month":396,"disease_response_os_unit":"month","disease_response_os":396,"disease_response_pfs":"No","tumor_size_measurement":52.0,"location":"Sydney","antibiotics_current_use":"No","dna_extraction_kit":"FastDNA","sequencing_platform":"NovaSeq","neutrophil_to_lymphocyte_ratio_measurement":2.36,"(uncurated)platelets":421,"albumin_in_g/dl":3.4,"lactate_dehydrogenase_measurement_in_u/l":271,"concentration":19.46,"number_bases":5811244966,"number_reads":38485066,"minimum_read_length":151,"median_read_length":151.0}
{"ncbi_accession":["ERR12406009"],"spots":19431927,"bases":5868441954,"biosample":"SAMEA12111356","sra_experiment":"ERX11782060","sra_sample":"ERS9758189","sra_study":"ERP134027","study_name":"GunjurA_2024","sample_id":"GunjurA_2024_119","subject_id":"GunjurA_2024_119","treatments":"Nivolumab,Ipilimumab,Proton Pump Inhibitor","age":45,"sex":"Female","country":"Austalia","bmi":25.67,"ecog performance status":1,"subcohort":"GYN","curator":"Alice_Bassetto; Paolo_Manghi","westernized":"Yes","disease_response_recist":"RECIST Partial Response","disease_response_pfs_month":798,"disease_response_os_unit":"month","disease_response_os":798,"disease_response_pfs":"Yes","tumor_size_measurement":182.0,"location":"Melbourne","antibiotics_current_use":"Yes","dna_extraction_kit":"FastDNA","sequencing_platform":"NovaSeq","neutrophil_to_lymphocyte_ratio_measurement":0.96,"(uncurated)platelets":313,"albumin_in_g/dl":4.0,"lactate_dehydrogenase_measurement_in_u/l":188,"concentration":112.13,"number_bases":5868441954,"number_reads":38863854,"minimum_read_length":151,"median_read_length":151.0}
{"ncbi_accession":["ERR12406000"],"spots":19894951,"bases":6008275202,"biosample":"SAMEA12111344","sra_experiment":"ERX11782051","sra_sample":"ERS9758177","sra_study":"ERP134027","study_name":"GunjurA_2024","sample_id":"GunjurA_2024_110","subject_id":"GunjurA_2024_110","treatments":"Nivolumab,Ipilimumab","age":63,"sex":"Female","country":"Austalia","bmi":30.65,"ecog performance status":0,"subcohort":"GYN","curator":"Alice_Bassetto; Paolo_Manghi","westernized":"Yes","disease_response_recist":"RECIST Progressive Disease","disease_response_pfs_month":84,"disease_response_os_unit":"month","disease_response_os":609,"disease_response_pfs":"No","tumor_size_measurement":47.0,"location":"Melbourne","antibiotics_current_use":"No","dna_extraction_kit":"FastDNA","sequencing_platform":"NovaSeq","neutrophil_to_lymphocyte_ratio_measurement":3.07,"(uncurated)platelets":257,"albumin_in_g/dl":4.0,"lactate_dehydrogenase_measurement_in_u/l":165,"concentration":44.95,"number_bases":6008275202,"number_reads":39789902,"minimum_read_length":151,"median_read_length":151.0}
{"ncbi_accession":["ERR12405930"],"spots":17295495,"bases":5223239490,"biosample":"SAMEA12111381","sra_experiment":"ERX11781981","sra_sample":"ERS9758214","sra_study":"ERP134027","study_name":"GunjurA_2024","sample_id":"GunjurA_2024_22","subject_id":"GunjurA_2024_22","treatments":"Nivolumab,Ipilimumab","age":82,"sex":"Female","country":"Austalia","bmi":28.18,"ecog performance status":1,"subcohort":"NEN","curator":"Alice_Bassetto; Paolo_Manghi","westernized":"Yes","disease_response_recist":"RECIST Stable Disease","disease_response_pfs_month":79,"disease_response_os_unit":"month","disease_response_os":744,"disease_response_pfs":"No","tumor_size_measurement":77.0,"location":"Melbourne","antibiotics_current_use":"No","dna_extraction_kit":"FastDNA","sequencing_platform":"NovaSeq","neutrophil_to_lymphocyte_ratio_measurement":8.3,"(uncurated)platelets":169,"albumin_in_g/dl":3.7,"lactate_dehydrogenase_measurement_in_u/l":255,"concentration":112.93,"number_bases":5223239490,"number_reads":34590990,"minimum_read_length":151,"median_read_length":151.0}
{"ncbi_accession":["ERR12405958"],"spots":22210717,"bases":6707636534,"biosample":"SAMEA12111287","sra_experiment":"ERX11782009","sra_sample":"ERS9758120","sra_study":"ERP134027","study_name":"GunjurA_2024","sample_id":"GunjurA_2024_68","subject_id":"GunjurA_2024_68","treatments":"Nivolumab,Ipilimumab,Chemoradiotherapy","age":55,"sex":"Female","country":"Austalia","bmi":32.76,"ecog performance status":1,"subcohort":"GYN","curator":"Alice_Bassetto; Paolo_Manghi","westernized":"Yes","disease_response_recist":"RECIST Stable Disease","disease_response_pfs_month":244,"disease_response_os_unit":"month","disease_response_os":1368,"disease_response_pfs":"No","tumor_size_measurement":118.0,"location":"Melbourne","antibiotics_current_use":"No","dna_extraction_kit":"FastDNA","sequencing_platform":"NovaSeq","neutrophil_to_lymphocyte_ratio_measurement":4.5,"(uncurated)platelets":431,"albumin_in_g/dl":3.3,"lactate_dehydrogenase_measurement_in_u/l":328,"concentration":167.95,"number_bases":6707636534,"number_reads":44421434,"minimum_read_length":151,"median_read_length":151.0}
{"ncbi_accession":["ERR12405916"],"spots":15331918,"bases":4630239236,"biosample":"SAMEA12111371","sra_experiment":"ERX11781967","sra_sample":"ERS9758204","sra_study":"ERP134027","study_name":"GunjurA_2024","sample_id":"GunjurA_2024_8","subject_id":"GunjurA_2024_8","treatments":"Nivolumab,Ipilimumab,Proton Pump Inhibitor","age":65,"sex":"Male","country":"Austalia","bmi":19.1,"ecog performance status":1,"subcohort":"NEN","curator":"Alice_Bassetto; Paolo_Manghi","westernized":"Yes","disease_response_recist":"RECIST Progressive Disease","disease_response_pfs_month":39,"disease_response_os_unit":"month","disease_response_os":172,"disease_response_pfs":"No","tumor_size_measurement":30.0,"location":"Albury","antibiotics_current_use":"No","dna_extraction_kit":"FastDNA","sequencing_platform":"NovaSeq","neutrophil_to_lymphocyte_ratio_measurement":6.33,"(uncurated)platelets":87,"albumin_in_g/dl":3.4,"lactate_dehydrogenase_measurement_in_u/l":503,"concentration":48.44,"number_bases":4630239236,"number_reads":30663836,"minimum_read_length":151,"median_read_length":151.0}
{"ncbi_accession":["ERR12405938"],"spots":21249937,"bases":6417480974,"biosample":"SAMEA12111345","sra_experiment":"ERX11781989","sra_sample":"ERS9758178","sra_study":"ERP134027","study_name":"GunjurA_2024","sample_id":"GunjurA_2024_37","subject_id":"GunjurA_2024_37","treatments":"Nivolumab,Ipilimumab,Proton Pump Inhibitor,Chemoradiotherapy","age":74,"sex":"Female","country":"Austalia","bmi":19.96,"ecog performance status":1,"subcohort":"GYN","curator":"Alice_Bassetto; Paolo_Manghi","westernized":"Yes","disease_response_recist":"RECIST Partial Response","disease_response_pfs_month":928,"disease_response_os_unit":"month","disease_response_os":928,"disease_response_pfs":"Yes","tumor_size_measurement":190.0,"location":"Melbourne","antibiotics_current_use":"No","dna_extraction_kit":"FastDNA","sequencing_platform":"NovaSeq","neutrophil_to_lymphocyte_ratio_measurement":1.4,"(uncurated)platelets":277,"albumin_in_g/dl":3.2,"lactate_dehydrogenase_measurement_in_u/l":307,"concentration":24.22,"number_bases":6417480974,"number_reads":42499874,"minimum_read_length":151,"median_read_length":151.0}
{"ncbi_accession":["ERR12405939"],"spots":19121164,"bases":5774591528,"biosample":"SAMEA12111348","sra_experiment":"ERX11781990","sra_sample":"ERS9758180","sra_study":"ERP134027","study_name":"GunjurA_2024","sample_id":"GunjurA_2024_39","subject_id":"GunjurA_2024_39","treatments":"Nivolumab,Ipilimumab","age":71,"sex":"Male","country":"Austalia","bmi":19.29,"ecog performance status":1,"subcohort":"UGB","curator":"Alice_Bassetto; Paolo_Manghi","westernized":"Yes","disease_response_recist":"RECIST Progressive Disease","disease_response_pfs_month":18,"disease_response_os_unit":"month","disease_response_os":18,"disease_response_pfs":"No","tumor_size_measurement":88.0,"location":"Albury","antibiotics_current_use":"No","dna_extraction_kit":"FastDNA","sequencing_platform":"NovaSeq","neutrophil_to_lymphocyte_ratio_measurement":66.0,"(uncurated)platelets":319,"albumin_in_g/dl":3.5,"lactate_dehydrogenase_measurement_in_u/l":469,"concentration":35.05,"number_bases":5774591528,"number_reads":38242328,"minimum_read_length":151,"median_read_length":151.0}
{"ncbi_accession":["ERR12405946"],"spots":20646135,"bases":6235132770,"biosample":"SAMEA12111372","sra_experiment":"ERX11781997","sra_sample":"ERS9758205","sra_study":"ERP134027","study_name":"GunjurA_2024","sample_id":"GunjurA_2024_54","subject_id":"GunjurA_2024_54","treatments":"Nivolumab,Ipilimumab","age":57,"sex":"Female","country":"Austalia","bmi":37.03,"ecog performance status":0,"subcohort":"GYN","curator":"Alice_Bassetto; Paolo_Manghi","westernized":"Yes","disease_response_recist":"RECIST Progressive Disease","disease_response_pfs_month":84,"disease_response_os_unit":"month","disease_response_os":686,"disease_response_pfs":"No","tumor_size_measurement":29.0,"location":"Sydney","antibiotics_current_use":"No","dna_extraction_kit":"FastDNA","sequencing_platform":"NovaSeq","neutrophil_to_lymphocyte_ratio_measurement":0.97,"(uncurated)platelets":318,"albumin_in_g/dl":3.6,"lactate_dehydrogenase_measurement_in_u/l":242,"concentration":17.92,"number_bases":6235132770,"number_reads":41292270,"minimum_read_length":151,"median_read_length":151.0}
{"ncbi_accession":["ERR12406012"],"spots":21031082,"bases":6351386764,"biosample":"SAMEA12111359","sra_experiment":"ERX11782063","sra_sample":"ERS9758192","sra_study":"ERP134027","study_name":"GunjurA_2024","sample_id":"GunjurA_2024_122","subject_id":"GunjurA_2024_122","treatments":"Nivolumab,Ipilimumab","age":81,"sex":"Female","country":"Austalia","bmi":25.39,"ecog performance status":0,"subcohort":"UGB","curator":"Alice_Bassetto; Paolo_Manghi","westernized":"Yes","disease_response_recist":"RECIST Stable Disease","disease_response_pfs_month":136,"disease_response_os_unit":"month","disease_response_os":277,"disease_response_pfs":"No","tumor_size_measurement":178.0,"location":"Albury","antibiotics_current_use":"No","dna_extraction_kit":"FastDNA","sequencing_platform":"NovaSeq","neutrophil_to_lymphocyte_ratio_measurement":4.92,"(uncurated)platelets":354,"albumin_in_g/dl":2.7,"lactate_dehydrogenase_measurement_in_u/l":912,"concentration":42.1,"number_bases":6351386764,"number_reads":42062164,"minimum_read_length":151,"median_read_length":151.0}
{"ncbi_accession":["ERR12405928"],"spots":21496016,"bases":6491796832,"biosample":"SAMEA12111332","sra_experiment":"ERX11781979","sra_sample":"ERS9758163","sra_study":"ERP134027","study_name":"GunjurA_2024","sample_id":"GunjurA_2024_20","subject_id":"GunjurA_2024_20","treatments":"Nivolumab,Ipilimumab","age":64,"sex":"Female","country":"Austalia","bmi":30.08,"ecog performance status":1,"subcohort":"GYN","curator":"Alice_Bassetto; Paolo_Manghi","westernized":"Yes","disease_response_recist":"RECIST Progressive Disease","disease_response_pfs_month":83,"disease_response_os_unit":"month","disease_response_os":401,"disease_response_pfs":"No","tumor_size_measurement":36.0,"location":"Melbourne","antibiotics_current_use":"No","dna_extraction_kit":"FastDNA","sequencing_platform":"NovaSeq","neutrophil_to_lymphocyte_ratio_measurement":4.0,"(uncurated)platelets":250,"albumin_in_g/dl":3.7,"lactate_dehydrogenase_measurement_in_u/l":193,"concentration":29.44,"number_bases":6491796832,"number_reads":42992032,"minimum_read_length":151,"median_read_length":151.0}
{"ncbi_accession":["ERR12405994"],"spots":18450291,"bases":5571987882,"biosample":"SAMEA12111329","sra_experiment":"ERX11782045","sra_sample":"ERS9758162","sra_study":"ERP134027","study_name":"GunjurA_2024","sample_id":"GunjurA_2024_104","subject_id":"GunjurA_2024_104","treatments":"Nivolumab,Ipilimumab","age":57,"sex":"Female","country":"Austalia","bmi":34.05,"ecog performance status":0,"subcohort":"UGB","curator":"Alice_Bassetto; Paolo_Manghi","westernized":"Yes","disease_response_recist":"RECIST Progressive Disease","disease_response_pfs_month":43,"disease_response_os_unit":"month","disease_response_os":49,"disease_response_pfs":"No","tumor_size_measurement":64.0,"location":"Melbourne","antibiotics_current_use":"No","dna_extraction_kit":"FastDNA","sequencing_platform":"NovaSeq","neutrophil_to_lymphocyte_ratio_measurement":5.27,"(uncurated)platelets":229,"albumin_in_g/dl":2.9,"lactate_dehydrogenase_measurement_in_u/l":187,"concentration":86.77,"number_bases":5571987882,"number_reads":36900582,"minimum_read_length":151,"median_read_length":151.0}
{"ncbi_accession":["ERR12405912"],"spots":20359853,"bases":6148675606,"biosample":"SAMEA12111368","sra_experiment":"ERX11781963","sra_sample":"ERS9758201","sra_study":"ERP134027","study_name":"GunjurA_2024","sample_id":"GunjurA_2024_4","subject_id":"GunjurA_2024_4","treatments":"Nivolumab,Ipilimumab,Proton Pump Inhibitor","age":42,"sex":"Male","country":"Austalia","bmi":31.19,"ecog performance status":0,"subcohort":"UGB","curator":"Alice_Bassetto; Paolo_Manghi","westernized":"Yes","disease_response_recist":"RECIST Partial Response","disease_response_pfs_month":253,"disease_response_os_unit":"month","disease_response_os":403,"disease_response_pfs":"No","tumor_size_measurement":11.0,"location":"Melbourne","antibiotics_current_use":"No","dna_extraction_kit":"FastDNA","sequencing_platform":"NovaSeq","neutrophil_to_lymphocyte_ratio_measurement":8.75,"(uncurated)platelets":225,"albumin_in_g/dl":3.7,"lactate_dehydrogenase_measurement_in_u/l":422,"concentration":124.02,"number_bases":6148675606,"number_reads":40719706,"minimum_read_length":151,"median_read_length":151.0}
{"ncbi_accession":["ERR12405945"],"spots":19619428,"bases":5925067256,"biosample":"SAMEA12111365","sra_experiment":"ERX11781996","sra_sample":"ERS9758198","sra_study":"ERP134027","study_name":"GunjurA_2024","sample_id":"GunjurA_2024_51","subject_id":"GunjurA_2024_51","treatments":"Nivolumab,Ipilimumab,Proton Pump Inhibitor,Chemoradiotherapy","age":52,"sex":"Female","country":"Austalia","bmi":33.49,"ecog performance status":1,"subcohort":"GYN","curator":"Alice_Bassetto; Paolo_Manghi","westernized":"Yes","disease_response_recist":"RECIST Progressive Disease","disease_response_pfs_month":31,"disease_response_os_unit":"month","disease_response_os":31,"disease_response_pfs":"No","tumor_size_measurement":208.0,"location":"Melbourne","antibiotics_current_use":"No","dna_extraction_kit":"FastDNA","sequencing_platform":"NovaSeq","neutrophil_to_lymphocyte_ratio_measurement":2.22,"(uncurated)platelets":352,"albumin_in_g/dl":3.2,"lactate_dehydrogenase_measurement_in_u/l":424,"concentration":12.55,"number_bases":5925067256,"number_reads":39238856,"minimum_read_length":151,"median_read_length":151.0}
{"ncbi_accession":["ERR12405968"],"spots":20047199,"bases":6054254098,"biosample":"SAMEA12111301","sra_experiment":"ERX11782019","sra_sample":"ERS9758132","sra_study":"ERP134027","study_name":"GunjurA_2024","sample_id":"GunjurA_2024_78","subject_id":"GunjurA_2024_78","treatments":"Nivolumab,Ipilimumab,Proton Pump Inhibitor","age":56,"sex":"Female","country":"Austalia","bmi":21.72,"ecog performance status":1,"subcohort":"UGB","curator":"Alice_Bassetto; Paolo_Manghi","westernized":"Yes","disease_response_recist":"RECIST Partial Response","disease_response_pfs_month":1282,"disease_response_os_unit":"month","disease_response_os":1282,"disease_response_pfs":"Yes","tumor_size_measurement":226.0,"location":"Melbourne","antibiotics_current_use":"No","dna_extraction_kit":"FastDNA","sequencing_platform":"NovaSeq","neutrophil_to_lymphocyte_ratio_measurement":6.67,"(uncurated)platelets":554,"albumin_in_g/dl":3.1,"lactate_dehydrogenase_measurement_in_u/l":297,"concentration":210.04,"number_bases":6054254098,"number_reads":40094398,"minimum_read_length":151,"median_read_length":151.0}
{"ncbi_accession":["ERR12406003"],"spots":18983998,"bases":5733167396,"biosample":"SAMEA12111347","sra_experiment":"ERX11782054","sra_sample":"ERS9758181","sra_study":"ERP134027","study_name":"GunjurA_2024","sample_id":"GunjurA_2024_113","subject_id":"GunjurA_2024_113","treatments":"Nivolumab,Ipilimumab","age":72,"sex":"Female","country":"Austalia","bmi":24.38,"ecog performance status":0,"subcohort":"GYN","curator":"Alice_Bassetto; Paolo_Manghi","westernized":"Yes","disease_response_recist":"RECIST Partial Response","disease_response_pfs_month":203,"disease_response_os_unit":"month","disease_response_os":883,"disease_response_pfs":"No","tumor_size_measurement":33.0,"location":"Sydney","antibiotics_current_use":"No","dna_extraction_kit":"FastDNA","sequencing_platform":"NovaSeq","neutrophil_to_lymphocyte_ratio_measurement":1.06,"(uncurated)platelets":153,"albumin_in_g/dl":3.6,"lactate_dehydrogenase_measurement_in_u/l":140,"concentration":111.05,"number_bases":5733167396,"number_reads":37967996,"minimum_read_length":151,"median_read_length":151.0}
{"ncbi_accession":["ERR12405966"],"spots":21581123,"bases":6517499146,"biosample":"SAMEA12111297","sra_experiment":"ERX11782017","sra_sample":"ERS9758130","sra_study":"ERP134027","study_name":"GunjurA_2024","sample_id":"GunjurA_2024_76","subject_id":"GunjurA_2024_76","treatments":"Nivolumab,Ipilimumab","age":59,"sex":"Female","country":"Austalia","bmi":34.61,"ecog performance status":0,"subcohort":"GYN","curator":"Alice_Bassetto; Paolo_Manghi","westernized":"Yes","disease_response_recist":"RECIST Stable Disease","disease_response_pfs_month":170,"disease_response_os_unit":"month","disease_response_os":1304,"disease_response_pfs":"No","tumor_size_measurement":17.0,"location":"Melbourne","antibiotics_current_use":"No","dna_extraction_kit":"FastDNA","sequencing_platform":"NovaSeq","neutrophil_to_lymphocyte_ratio_measurement":1.48,"(uncurated)platelets":189,"albumin_in_g/dl":3.6,"lactate_dehydrogenase_measurement_in_u/l":321,"concentration":97.22,"number_bases":6517499146,"number_reads":43162246,"minimum_read_length":151,"median_read_length":151.0}
{"ncbi_accession":["ERR12405935"],"spots":19863081,"bases":5998650462,"biosample":"SAMEA12111340","sra_experiment":"ERX11781986","sra_sample":"ERS9758173","sra_study":"ERP134027","study_name":"GunjurA_2024","sample_id":"GunjurA_2024_32","subject_id":"GunjurA_2024_32","treatments":"Nivolumab,Ipilimumab","age":47,"sex":"Female","country":"Austalia","bmi":38.04,"ecog performance status":0,"subcohort":"GYN","curator":"Alice_Bassetto; Paolo_Manghi","westernized":"Yes","disease_response_recist":"RECIST Stable Disease","disease_response_pfs_month":862,"disease_response_os_unit":"month","disease_response_os":862,"disease_response_pfs":"Yes","tumor_size_measurement":54.0,"location":"Sydney","antibiotics_current_use":"No","dna_extraction_kit":"FastDNA","sequencing_platform":"NovaSeq","neutrophil_to_lymphocyte_ratio_measurement":1.43,"(uncurated)platelets":216,"albumin_in_g/dl":4.1,"lactate_dehydrogenase_measurement_in_u/l":222,"concentration":18.87,"number_bases":5998650462,"number_reads":39726162,"minimum_read_length":151,"median_read_length":151.0}
{"ncbi_accession":["ERR12405920"],"spots":18850410,"bases":5692823820,"biosample":"SAMEA12111292","sra_experiment":"ERX11781971","sra_sample":"ERS9758125","sra_study":"ERP134027","study_name":"GunjurA_2024","sample_id":"GunjurA_2024_12","subject_id":"GunjurA_2024_12","treatments":"Nivolumab,Ipilimumab,Proton Pump Inhibitor,Chemoradiotherapy","age":66,"sex":"Male","country":"Austalia","bmi":19.76,"ecog performance status":1,"subcohort":"UGB","curator":"Alice_Bassetto; Paolo_Manghi","westernized":"Yes","disease_response_recist":"RECIST Progressive Disease","disease_response_pfs_month":24,"disease_response_os_unit":"month","disease_response_os":24,"disease_response_pfs":"No","tumor_size_measurement":109.0,"location":"Melbourne","antibiotics_current_use":"No","dna_extraction_kit":"FastDNA","sequencing_platform":"NovaSeq","neutrophil_to_lymphocyte_ratio_measurement":6.0,"(uncurated)platelets":372,"albumin_in_g/dl":3.3,"lactate_dehydrogenase_measurement_in_u/l":193,"concentration":14.2,"number_bases":5692823820,"number_reads":37700820,"minimum_read_length":151,"median_read_length":151.0}
{"ncbi_accession":["ERR12405998"],"spots":21219207,"bases":6408200514,"biosample":"SAMEA12111335","sra_experiment":"ERX11782049","sra_sample":"ERS9758168","sra_study":"ERP134027","study_name":"GunjurA_2024","sample_id":"GunjurA_2024_108","subject_id":"GunjurA_2024_108","treatments":"Nivolumab,Ipilimumab,Proton Pump Inhibitor","age":70,"sex":"Male","country":"Austalia","bmi":34.58,"ecog performance status":0,"subcohort":"UGB","curator":"Alice_Bassetto; Paolo_Manghi","westernized":"Yes","disease_response_recist":"RECIST Stable Disease","disease_response_pfs_month":267,"disease_response_os_unit":"month","disease_response_os":675,"disease_response_pfs":"No","tumor_size_measurement":57.0,"location":"Sydney","antibiotics_current_use":"No","dna_extraction_kit":"FastDNA","sequencing_platform":"NovaSeq","neutrophil_to_lymphocyte_ratio_measurement":1.0,"(uncurated)platelets":167,"albumin_in_g/dl":3.6,"lactate_dehydrogenase_measurement_in_u/l":180,"concentration":190.67,"number_bases":6408200514,"number_reads":42438414,"minimum_read_length":151,"median_read_length":151.0}
{"ncbi_accession":["ERR12405925"],"spots":18483353,"bases":5581972606,"biosample":"SAMEA12111321","sra_experiment":"ERX11781976","sra_sample":"ERS9758153","sra_study":"ERP134027","study_name":"GunjurA_2024","sample_id":"GunjurA_2024_17","subject_id":"GunjurA_2024_17","treatments":"Nivolumab,Ipilimumab","age":73,"sex":"Male","country":"Austalia","bmi":31.89,"ecog performance status":0,"subcohort":"UGB","curator":"Alice_Bassetto; Paolo_Manghi","westernized":"Yes","disease_response_recist":"RECIST Progressive Disease","disease_response_pfs_month":83,"disease_response_os_unit":"month","disease_response_os":340,"disease_response_pfs":"No","tumor_size_measurement":24.0,"location":"Melbourne","antibiotics_current_use":"No","dna_extraction_kit":"FastDNA","sequencing_platform":"NovaSeq","neutrophil_to_lymphocyte_ratio_measurement":1.57,"(uncurated)platelets":191,"albumin_in_g/dl":3.9,"lactate_dehydrogenase_measurement_in_u/l":271,"concentration":38.11,"number_bases":5581972606,"number_reads":36966706,"minimum_read_length":151,"median_read_length":151.0}
{"ncbi_accession":["ERR12405949"],"spots":21748498,"bases":6568046396,"biosample":"SAMEA12111375","sra_experiment":"ERX11782000","sra_sample":"ERS9758210","sra_study":"ERP134027","study_name":"GunjurA_2024","sample_id":"GunjurA_2024_59","subject_id":"GunjurA_2024_59","treatments":"Nivolumab,Ipilimumab,Proton Pump Inhibitor,Chemoradiotherapy","age":20,"sex":"Male","country":"Austalia","bmi":25.05,"ecog performance status":1,"subcohort":"NEN","curator":"Alice_Bassetto; Paolo_Manghi","westernized":"Yes","disease_response_recist":"RECIST Progressive Disease","disease_response_pfs_month":22,"disease_response_os_unit":"month","disease_response_os":22,"disease_response_pfs":"No","tumor_size_measurement":56.0,"location":"Melbourne","antibiotics_current_use":"No","dna_extraction_kit":"FastDNA","sequencing_platform":"NovaSeq","neutrophil_to_lymphocyte_ratio_measurement":4.17,"(uncurated)platelets":236,"albumin_in_g/dl":3.4,"lactate_dehydrogenase_measurement_in_u/l":264,"concentration":27.4,"number_bases":6568046396,"number_reads":43496996,"minimum_read_length":151,"median_read_length":151.0}
{"ncbi_accession":["ERR12405987"],"spots":16092316,"bases":4859879432,"biosample":"SAMEA12111319","sra_experiment":"ERX11782038","sra_sample":"ERS9758152","sra_study":"ERP134027","study_name":"GunjurA_2024","sample_id":"GunjurA_2024_97","subject_id":"GunjurA_2024_97","treatments":"Nivolumab,Ipilimumab","age":71,"sex":"Female","country":"Austalia","bmi":22.95,"ecog performance status":0,"subcohort":"NEN","curator":"Alice_Bassetto; Paolo_Manghi","westernized":"Yes","disease_response_recist":"RECIST Stable Disease","disease_response_pfs_month":180,"disease_response_os_unit":"month","disease_response_os":1063,"disease_response_pfs":"No","tumor_size_measurement":103.0,"location":"Melbourne","antibiotics_current_use":"No","dna_extraction_kit":"FastDNA","sequencing_platform":"NovaSeq","neutrophil_to_lymphocyte_ratio_measurement":2.72,"(uncurated)platelets":318,"albumin_in_g/dl":4.3,"lactate_dehydrogenase_measurement_in_u/l":200,"concentration":64.81,"number_bases":4859879432,"number_reads":32184632,"minimum_read_length":151,"median_read_length":151.0}
{"ncbi_accession":["ERR12406008"],"spots":18316431,"bases":5531562162,"biosample":"SAMEA12111355","sra_experiment":"ERX11782059","sra_sample":"ERS9758188","sra_study":"ERP134027","study_name":"GunjurA_2024","sample_id":"GunjurA_2024_118","subject_id":"GunjurA_2024_118","treatments":"Nivolumab,Ipilimumab","age":62,"sex":"Female","country":"Austalia","bmi":23.79,"ecog performance status":0,"subcohort":"GYN","curator":"Alice_Bassetto; Paolo_Manghi","westernized":"Yes","disease_response_recist":"RECIST Progressive Disease","disease_response_pfs_month":83,"disease_response_os_unit":"month","disease_response_os":161,"disease_response_pfs":"No","tumor_size_measurement":131.0,"location":"Melbourne","antibiotics_current_use":"No","dna_extraction_kit":"FastDNA","sequencing_platform":"NovaSeq","neutrophil_to_lymphocyte_ratio_measurement":4.8,"(uncurated)platelets":294,"albumin_in_g/dl":2.9,"lactate_dehydrogenase_measurement_in_u/l":268,"concentration":58.15,"number_bases":5531562162,"number_reads":36632862,"minimum_read_length":151,"median_read_length":151.0}
{"ncbi_accession":["ERR12405982"],"spots":23420077,"bases":7072863254,"biosample":"SAMEA12111315","sra_experiment":"ERX11782033","sra_sample":"ERS9758148","sra_study":"ERP134027","study_name":"GunjurA_2024","sample_id":"GunjurA_2024_92","subject_id":"GunjurA_2024_92","treatments":"Nivolumab,Ipilimumab","age":43,"sex":"Female","country":"Austalia","bmi":34.78,"ecog performance status":0,"subcohort":"UGB","curator":"Alice_Bassetto; Paolo_Manghi","westernized":"Yes","disease_response_recist":"RECIST Partial Response","disease_response_pfs_month":255,"disease_response_os_unit":"month","disease_response_os":646,"disease_response_pfs":"No","tumor_size_measurement":18.0,"location":"Melbourne","antibiotics_current_use":"No","dna_extraction_kit":"FastDNA","sequencing_platform":"NovaSeq","neutrophil_to_lymphocyte_ratio_measurement":2.45,"(uncurated)platelets":171,"albumin_in_g/dl":3.8,"lactate_dehydrogenase_measurement_in_u/l":394,"concentration":183.55,"number_bases":7072863254,"number_reads":46840154,"minimum_read_length":151,"median_read_length":151.0}
{"ncbi_accession":["ERR12405941"],"spots":18759105,"bases":5665249710,"biosample":"SAMEA12111353","sra_experiment":"ERX11781992","sra_sample":"ERS9758187","sra_study":"ERP134027","study_name":"GunjurA_2024","sample_id":"GunjurA_2024_43","subject_id":"GunjurA_2024_43","treatments":"Nivolumab,Ipilimumab,Proton Pump Inhibitor","age":73,"sex":"Male","country":"Austalia","bmi":30.7,"ecog performance status":1,"subcohort":"UGB","curator":"Alice_Bassetto; Paolo_Manghi","westernized":"Yes","disease_response_recist":"RECIST Progressive Disease","disease_response_pfs_month":29,"disease_response_os_unit":"month","disease_response_os":30,"disease_response_pfs":"No","tumor_size_measurement":42.0,"location":"Sydney","antibiotics_current_use":"Yes","dna_extraction_kit":"FastDNA","sequencing_platform":"NovaSeq","neutrophil_to_lymphocyte_ratio_measurement":2.44,"(uncurated)platelets":100,"albumin_in_g/dl":2.0,"lactate_dehydrogenase_measurement_in_u/l":225,"concentration":37.94,"number_bases":5665249710,"number_reads":37518210,"minimum_read_length":151,"median_read_length":151.0}
{"ncbi_accession":["ERR12405910"],"spots":21761630,"bases":6572012260,"biosample":"SAMEA12111276","sra_experiment":"ERX11781961","sra_sample":"ERS9758109","sra_study":"ERP134027","study_name":"GunjurA_2024","sample_id":"GunjurA_2024_2","subject_id":"GunjurA_2024_2","treatments":"Nivolumab,Ipilimumab,Proton Pump Inhibitor","age":37,"sex":"Female","country":"Austalia","bmi":21.34,"ecog performance status":1,"subcohort":"UGB","curator":"Alice_Bassetto; Paolo_Manghi","westernized":"Yes","disease_response_recist":"RECIST Progressive Disease","disease_response_pfs_month":85,"disease_response_os_unit":"month","disease_response_os":558,"disease_response_pfs":"No","tumor_size_measurement":47.0,"location":"Melbourne","antibiotics_current_use":"No","dna_extraction_kit":"FastDNA","sequencing_platform":"NovaSeq","neutrophil_to_lymphocyte_ratio_measurement":3.8,"(uncurated)platelets":250,"albumin_in_g/dl":3.6,"lactate_dehydrogenase_measurement_in_u/l":211,"concentration":31.92,"number_bases":6572012260,"number_reads":43523260,"minimum_read_length":151,"median_read_length":151.0}
{"ncbi_accession":["ERR12405934"],"spots":21660373,"bases":6541432646,"biosample":"SAMEA12111338","sra_experiment":"ERX11781985","sra_sample":"ERS9758172","sra_study":"ERP134027","study_name":"GunjurA_2024","sample_id":"GunjurA_2024_29","subject_id":"GunjurA_2024_29","treatments":"Nivolumab,Ipilimumab,Proton Pump Inhibitor","age":66,"sex":"Female","country":"Austalia","bmi":21.55,"ecog performance status":1,"subcohort":"UGB","curator":"Alice_Bassetto; Paolo_Manghi","westernized":"Yes","disease_response_recist":"RECIST Progressive Disease","disease_response_pfs_month":77,"disease_response_os_unit":"month","disease_response_os":130,"disease_response_pfs":"No","tumor_size_measurement":113.0,"location":"Sydney","antibiotics_current_use":"No","dna_extraction_kit":"FastDNA","sequencing_platform":"NovaSeq","neutrophil_to_lymphocyte_ratio_measurement":1.78,"(uncurated)platelets":295,"albumin_in_g/dl":3.8,"lactate_dehydrogenase_measurement_in_u/l":192,"concentration":32.59,"number_bases":6541432646,"number_reads":43320746,"minimum_read_length":151,"median_read_length":151.0}
{"ncbi_accession":["ERR12405955"],"spots":21815376,"bases":6588243552,"biosample":"SAMEA12111284","sra_experiment":"ERX11782006","sra_sample":"ERS9758117","sra_study":"ERP134027","study_name":"GunjurA_2024","sample_id":"GunjurA_2024_65","subject_id":"GunjurA_2024_65","treatments":"Nivolumab,Ipilimumab,Proton Pump Inhibitor","age":58,"sex":"Female","country":"Austalia","bmi":25.76,"ecog performance status":1,"subcohort":"GYN","curator":"Alice_Bassetto; Paolo_Manghi","westernized":"Yes","disease_response_recist":"RECIST Complete Response","disease_response_pfs_month":708,"disease_response_os_unit":"month","disease_response_os":1345,"disease_response_pfs":"No","tumor_size_measurement":42.0,"location":"Melbourne","antibiotics_current_use":"No","dna_extraction_kit":"FastDNA","sequencing_platform":"NovaSeq","neutrophil_to_lymphocyte_ratio_measurement":2.62,"(uncurated)platelets":313,"albumin_in_g/dl":3.5,"lactate_dehydrogenase_measurement_in_u/l":339,"concentration":261.13,"number_bases":6588243552,"number_reads":43630752,"minimum_read_length":151,"median_read_length":151.0}
{"ncbi_accession":["ERR12405993"],"spots":19542618,"bases":5901870636,"biosample":"SAMEA12111327","sra_experiment":"ERX11782044","sra_sample":"ERS9758160","sra_study":"ERP134027","study_name":"GunjurA_2024","sample_id":"GunjurA_2024_103","subject_id":"GunjurA_2024_103","treatments":"Nivolumab,Ipilimumab","age":27,"sex":"Male","country":"Austalia","bmi":31.75,"ecog performance status":1,"subcohort":"NEN","curator":"Alice_Bassetto; Paolo_Manghi","westernized":"Yes","disease_response_recist":"RECIST Progressive Disease","disease_response_pfs_month":70,"disease_response_os_unit":"month","disease_response_os":1005,"disease_response_pfs":"No","tumor_size_measurement":61.0,"location":"Melbourne","antibiotics_current_use":"No","dna_extraction_kit":"FastDNA","sequencing_platform":"NovaSeq","neutrophil_to_lymphocyte_ratio_measurement":1.44,"(uncurated)platelets":295,"albumin_in_g/dl":4.2,"lactate_dehydrogenase_measurement_in_u/l":324,"concentration":49.08,"number_bases":5901870636,"number_reads":39085236,"minimum_read_length":151,"median_read_length":151.0}
{"ncbi_accession":["ERR12405924"],"spots":18353567,"bases":5542777234,"biosample":"SAMEA12111313","sra_experiment":"ERX11781975","sra_sample":"ERS9758146","sra_study":"ERP134027","study_name":"GunjurA_2024","sample_id":"GunjurA_2024_16","subject_id":"GunjurA_2024_16","treatments":"Nivolumab,Ipilimumab,Proton Pump Inhibitor","age":55,"sex":"Male","country":"Austalia","bmi":26.35,"ecog performance status":1,"subcohort":"NEN","curator":"Alice_Bassetto; Paolo_Manghi","westernized":"Yes","disease_response_recist":"RECIST Progressive Disease","disease_response_pfs_month":23,"disease_response_os_unit":"month","disease_response_os":27,"disease_response_pfs":"No","tumor_size_measurement":189.0,"location":"Melbourne","antibiotics_current_use":"No","dna_extraction_kit":"FastDNA","sequencing_platform":"NovaSeq","neutrophil_to_lymphocyte_ratio_measurement":9.8,"(uncurated)platelets":241,"albumin_in_g/dl":3.7,"lactate_dehydrogenase_measurement_in_u/l":503,"concentration":32.62,"number_bases":5542777234,"number_reads":36707134,"minimum_read_length":151,"median_read_length":151.0}
{"ncbi_accession":["ERR12406002"],"spots":20087735,"bases":6066495970,"biosample":"SAMEA12111346","sra_experiment":"ERX11782053","sra_sample":"ERS9758179","sra_study":"ERP134027","study_name":"GunjurA_2024","sample_id":"GunjurA_2024_112","subject_id":"GunjurA_2024_112","treatments":"Nivolumab,Ipilimumab,Proton Pump Inhibitor","age":55,"sex":"Male","country":"Austalia","bmi":25.44,"ecog performance status":0,"subcohort":"UGB","curator":"Alice_Bassetto; Paolo_Manghi","westernized":"Yes","disease_response_recist":"RECIST Stable Disease","disease_response_pfs_month":103,"disease_response_os_unit":"month","disease_response_os":257,"disease_response_pfs":"No","tumor_size_measurement":19.0,"location":"Melbourne","antibiotics_current_use":"No","dna_extraction_kit":"FastDNA","sequencing_platform":"NovaSeq","neutrophil_to_lymphocyte_ratio_measurement":2.63,"(uncurated)platelets":231,"albumin_in_g/dl":3.8,"lactate_dehydrogenase_measurement_in_u/l":198,"concentration":268.38,"number_bases":6066495970,"number_reads":40175470,"minimum_read_length":151,"median_read_length":151.0}
{"ncbi_accession":["ERR12406014"],"spots":19960209,"bases":6027983118,"biosample":"SAMEA12111363","sra_experiment":"ERX11782065","sra_sample":"ERS9758197","sra_study":"ERP134027","study_name":"GunjurA_2024","sample_id":"GunjurA_2024_124","subject_id":"GunjurA_2024_124","treatments":"Nivolumab,Ipilimumab","age":72,"sex":"Female","country":"Austalia","bmi":31.55,"ecog performance status":0,"subcohort":"NEN","curator":"Alice_Bassetto; Paolo_Manghi","westernized":"Yes","disease_response_recist":"RECIST Partial Response","disease_response_pfs_month":834,"disease_response_os_unit":"month","disease_response_os":834,"disease_response_pfs":"Yes","tumor_size_measurement":43.0,"location":"Sydney","antibiotics_current_use":"Yes","dna_extraction_kit":"FastDNA","sequencing_platform":"NovaSeq","neutrophil_to_lymphocyte_ratio_measurement":4.71,"(uncurated)platelets":397,"albumin_in_g/dl":3.5,"lactate_dehydrogenase_measurement_in_u/l":209,"concentration":142.9,"number_bases":6027983118,"number_reads":39920418,"minimum_read_length":151,"median_read_length":151.0}
{"ncbi_accession":["ERR12405947"],"spots":19853425,"bases":5995734350,"biosample":"SAMEA12111373","sra_experiment":"ERX11781998","sra_sample":"ERS9758206","sra_study":"ERP134027","study_name":"GunjurA_2024","sample_id":"GunjurA_2024_55","subject_id":"GunjurA_2024_55","treatments":"Nivolumab,Ipilimumab,Chemoradiotherapy","age":69,"sex":"Male","country":"Austalia","bmi":21.99,"ecog performance status":1,"subcohort":"NEN","curator":"Alice_Bassetto; Paolo_Manghi","westernized":"Yes","disease_response_recist":"RECIST Progressive Disease","disease_response_pfs_month":81,"disease_response_os_unit":"month","disease_response_os":530,"disease_response_pfs":"No","tumor_size_measurement":57.0,"location":"Melbourne","antibiotics_current_use":"No","dna_extraction_kit":"FastDNA","sequencing_platform":"NovaSeq","neutrophil_to_lymphocyte_ratio_measurement":1.31,"(uncurated)platelets":329,"albumin_in_g/dl":3.4,"lactate_dehydrogenase_measurement_in_u/l":196,"concentration":21.07,"number_bases":5995734350,"number_reads":39706850,"minimum_read_length":151,"median_read_length":151.0}
{"ncbi_accession":["ERR12405944"],"spots":18122468,"bases":5472985336,"biosample":"SAMEA12111364","sra_experiment":"ERX11781995","sra_sample":"ERS9758196","sra_study":"ERP134027","study_name":"GunjurA_2024","sample_id":"GunjurA_2024_50","subject_id":"GunjurA_2024_50","treatments":"Nivolumab,Ipilimumab","age":51,"sex":"Female","country":"Austalia","bmi":21.36,"ecog performance status":0,"subcohort":"GYN","curator":"Alice_Bassetto; Paolo_Manghi","westernized":"Yes","disease_response_recist":"RECIST Partial Response","disease_response_pfs_month":811,"disease_response_os_unit":"month","disease_response_os":811,"disease_response_pfs":"Yes","tumor_size_measurement":164.0,"location":"Sydney","antibiotics_current_use":"No","dna_extraction_kit":"FastDNA","sequencing_platform":"NovaSeq","neutrophil_to_lymphocyte_ratio_measurement":3.79,"(uncurated)platelets":559,"albumin_in_g/dl":3.6,"lactate_dehydrogenase_measurement_in_u/l":241,"concentration":38.12,"number_bases":5472985336,"number_reads":36244936,"minimum_read_length":151,"median_read_length":151.0}
{"ncbi_accession":["ERR12405942"],"spots":25309698,"bases":7643528796,"biosample":"SAMEA12111360","sra_experiment":"ERX11781993","sra_sample":"ERS9758193","sra_study":"ERP134027","study_name":"GunjurA_2024","sample_id":"GunjurA_2024_46","subject_id":"GunjurA_2024_46","treatments":"Nivolumab,Ipilimumab","age":68,"sex":"Female","country":"Austalia","bmi":28.36,"ecog performance status":0,"subcohort":"GYN","curator":"Alice_Bassetto; Paolo_Manghi","westernized":"Yes","disease_response_recist":"RECIST Stable Disease","disease_response_pfs_month":78,"disease_response_os_unit":"month","disease_response_os":827,"disease_response_pfs":"No","tumor_size_measurement":119.0,"location":"Sydney","antibiotics_current_use":"No","dna_extraction_kit":"FastDNA","sequencing_platform":"NovaSeq","neutrophil_to_lymphocyte_ratio_measurement":5.11,"(uncurated)platelets":176,"albumin_in_g/dl":3.2,"lactate_dehydrogenase_measurement_in_u/l":193,"concentration":37.93,"number_bases":7643528796,"number_reads":50619396,"minimum_read_length":151,"median_read_length":151.0}
{"ncbi_accession":["ERR12405940"],"spots":19007870,"bases":5740376740,"biosample":"SAMEA12111351","sra_experiment":"ERX11781991","sra_sample":"ERS9758184","sra_study":"ERP134027","study_name":"GunjurA_2024","sample_id":"GunjurA_2024_42","subject_id":"GunjurA_2024_42","treatments":"Nivolumab,Ipilimumab,Proton Pump Inhibitor","age":40,"sex":"Female","country":"Austalia","bmi":20.4,"ecog performance status":1,"subcohort":"NEN","curator":"Alice_Bassetto; Paolo_Manghi","westernized":"Yes","disease_response_recist":"RECIST Progressive Disease","disease_response_pfs_month":21,"disease_response_os_unit":"month","disease_response_os":28,"disease_response_pfs":"No","tumor_size_measurement":192.0,"location":"Melbourne","antibiotics_current_use":"Yes","dna_extraction_kit":"FastDNA","sequencing_platform":"NovaSeq","neutrophil_to_lymphocyte_ratio_measurement":6.83,"(uncurated)platelets":306,"albumin_in_g/dl":2.8,"lactate_dehydrogenase_measurement_in_u/l":598,"concentration":3.71,"number_bases":5740376740,"number_reads":38015740,"minimum_read_length":151,"median_read_length":151.0}
{"ncbi_accession":["ERR12406013"],"spots":20398405,"bases":6160318310,"biosample":"SAMEA12111361","sra_experiment":"ERX11782064","sra_sample":"ERS9758194","sra_study":"ERP134027","study_name":"GunjurA_2024","sample_id":"GunjurA_2024_123","subject_id":"GunjurA_2024_123","treatments":"Nivolumab,Ipilimumab","age":66,"sex":"Female","country":"Austalia","bmi":35.66,"ecog performance status":1,"subcohort":"GYN","curator":"Alice_Bassetto; Paolo_Manghi","westernized":"Yes","disease_response_recist":"RECIST Progressive Disease","disease_response_pfs_month":80,"disease_response_os_unit":"month","disease_response_os":104,"disease_response_pfs":"No","tumor_size_measurement":32.0,"location":"Melbourne","antibiotics_current_use":"No","dna_extraction_kit":"FastDNA","sequencing_platform":"NovaSeq","neutrophil_to_lymphocyte_ratio_measurement":4.0,"(uncurated)platelets":313,"albumin_in_g/dl":3.1,"lactate_dehydrogenase_measurement_in_u/l":183,"concentration":76.7,"number_bases":6160318310,"number_reads":40796810,"minimum_read_length":151,"median_read_length":151.0}
{"ncbi_accession":["ERR12406005"],"spots":17661768,"bases":5333853936,"biosample":"SAMEA12111349","sra_experiment":"ERX11782056","sra_sample":"ERS9758183","sra_study":"ERP134027","study_name":"GunjurA_2024","sample_id":"GunjurA_2024_115","subject_id":"GunjurA_2024_115","treatments":"Nivolumab,Ipilimumab,Proton Pump Inhibitor","age":65,"sex":"Male","country":"Austalia","bmi":21.6,"ecog performance status":1,"subcohort":"NEN","curator":"Alice_Bassetto; Paolo_Manghi","westernized":"Yes","disease_response_recist":"RECIST Stable Disease","disease_response_pfs_month":687,"disease_response_os_unit":"month","disease_response_os":752,"disease_response_pfs":"No","tumor_size_measurement":43.0,"location":"Albury","antibiotics_current_use":"No","dna_extraction_kit":"FastDNA","sequencing_platform":"NovaSeq","neutrophil_to_lymphocyte_ratio_measurement":10.0,"(uncurated)platelets":62,"albumin_in_g/dl":2.4,"lactate_dehydrogenase_measurement_in_u/l":295,"concentration":46.3,"number_bases":5333853936,"number_reads":35323536,"minimum_read_length":151,"median_read_length":151.0}
{"ncbi_accession":["ERR12405933"],"spots":23263636,"bases":7025618072,"biosample":"SAMEA12111339","sra_experiment":"ERX11781984","sra_sample":"ERS9758171","sra_study":"ERP134027","study_name":"GunjurA_2024","sample_id":"GunjurA_2024_28","subject_id":"GunjurA_2024_28","treatments":"Nivolumab,Ipilimumab,Proton Pump Inhibitor,Chemoradiotherapy","age":68,"sex":"Male","country":"Austalia","bmi":38.24,"ecog performance status":1,"subcohort":"UGB","curator":"Alice_Bassetto; Paolo_Manghi","westernized":"Yes","disease_response_recist":"RECIST Progressive Disease","disease_response_pfs_month":41,"disease_response_os_unit":"month","disease_response_os":41,"disease_response_pfs":"No","tumor_size_measurement":60.0,"location":"Albury","antibiotics_current_use":"Yes","dna_extraction_kit":"FastDNA","sequencing_platform":"NovaSeq","neutrophil_to_lymphocyte_ratio_measurement":3.24,"(uncurated)platelets":310,"albumin_in_g/dl":2.4,"lactate_dehydrogenase_measurement_in_u/l":352,"concentration":31.16,"number_bases":7025618072,"number_reads":46527272,"minimum_read_length":151,"median_read_length":151.0}
{"ncbi_accession":["ERR12405936"],"spots":9438084,"bases":2850301368,"biosample":"SAMEA12111343","sra_experiment":"ERX11781987","sra_sample":"ERS9758176","sra_study":"ERP134027","study_name":"GunjurA_2024","sample_id":"GunjurA_2024_33","subject_id":"GunjurA_2024_33","treatments":"Nivolumab,Ipilimumab,Proton Pump Inhibitor","age":66,"sex":"Female","country":"Austalia","bmi":22.19,"ecog performance status":1,"subcohort":"GYN","curator":"Alice_Bassetto; Paolo_Manghi","westernized":"Yes","disease_response_recist":"RECIST Progressive Disease","disease_response_pfs_month":49,"disease_response_os_unit":"month","disease_response_os":70,"disease_response_pfs":"No","tumor_size_measurement":44.0,"location":"Sydney","antibiotics_current_use":"No","dna_extraction_kit":"FastDNA","sequencing_platform":"NovaSeq","neutrophil_to_lymphocyte_ratio_measurement":3.67,"(uncurated)platelets":587,"albumin_in_g/dl":3.0,"lactate_dehydrogenase_measurement_in_u/l":300,"concentration":19.44,"number_bases":2850301368,"number_reads":18876168,"minimum_read_length":151,"median_read_length":151.0}
{"ncbi_accession":["ERR12406010"],"spots":21454857,"bases":6479366814,"biosample":"SAMEA12111357","sra_experiment":"ERX11782061","sra_sample":"ERS9758190","sra_study":"ERP134027","study_name":"GunjurA_2024","sample_id":"GunjurA_2024_120","subject_id":"GunjurA_2024_120","treatments":"Nivolumab,Ipilimumab","age":75,"sex":"Female","country":"Austalia","bmi":31.76,"ecog performance status":1,"subcohort":"GYN","curator":"Alice_Bassetto; Paolo_Manghi","westernized":"Yes","disease_response_recist":"RECIST Progressive Disease","disease_response_pfs_month":22,"disease_response_os_unit":"month","disease_response_os":22,"disease_response_pfs":"No","tumor_size_measurement":111.0,"location":"Melbourne","antibiotics_current_use":"No","dna_extraction_kit":"FastDNA","sequencing_platform":"NovaSeq","neutrophil_to_lymphocyte_ratio_measurement":14.8,"(uncurated)platelets":312,"albumin_in_g/dl":3.5,"lactate_dehydrogenase_measurement_in_u/l":218,"concentration":81.61,"number_bases":6479366814,"number_reads":42909714,"minimum_read_length":151,"median_read_length":151.0}
{"ncbi_accession":["ERR12405977"],"spots":18267077,"bases":5516657254,"biosample":"SAMEA12111309","sra_experiment":"ERX11782028","sra_sample":"ERS9758142","sra_study":"ERP134027","study_name":"GunjurA_2024","sample_id":"GunjurA_2024_87","subject_id":"GunjurA_2024_87","treatments":"Nivolumab,Ipilimumab,Chemoradiotherapy","age":47,"sex":"Female","country":"Austalia","bmi":28.01,"ecog performance status":0,"subcohort":"GYN","curator":"Alice_Bassetto; Paolo_Manghi","westernized":"Yes","disease_response_recist":"RECIST Progressive Disease","disease_response_pfs_month":31,"disease_response_os_unit":"month","disease_response_os":54,"disease_response_pfs":"No","tumor_size_measurement":162.0,"location":"Melbourne","antibiotics_current_use":"No","dna_extraction_kit":"FastDNA","sequencing_platform":"NovaSeq","neutrophil_to_lymphocyte_ratio_measurement":4.85,"(uncurated)platelets":378,"albumin_in_g/dl":2.9,"lactate_dehydrogenase_measurement_in_u/l":468,"concentration":42.0,"number_bases":5516657254,"number_reads":36534154,"minimum_read_length":151,"median_read_length":151.0}
{"ncbi_accession":["ERR12405961"],"spots":21096465,"bases":6371132430,"biosample":"SAMEA12111291","sra_experiment":"ERX11782012","sra_sample":"ERS9758124","sra_study":"ERP134027","study_name":"GunjurA_2024","sample_id":"GunjurA_2024_71","subject_id":"GunjurA_2024_71","treatments":"Nivolumab,Ipilimumab","age":72,"sex":"Male","country":"Austalia","bmi":32.23,"ecog performance status":1,"subcohort":"NEN","curator":"Alice_Bassetto; Paolo_Manghi","westernized":"Yes","disease_response_recist":"RECIST Progressive Disease","disease_response_pfs_month":79,"disease_response_os_unit":"month","disease_response_os":711,"disease_response_pfs":"No","tumor_size_measurement":121.0,"location":"Melbourne","antibiotics_current_use":"No","dna_extraction_kit":"FastDNA","sequencing_platform":"NovaSeq","neutrophil_to_lymphocyte_ratio_measurement":1.83,"(uncurated)platelets":203,"albumin_in_g/dl":3.9,"lactate_dehydrogenase_measurement_in_u/l":208,"concentration":121.36,"number_bases":6371132430,"number_reads":42192930,"minimum_read_length":151,"median_read_length":151.0}
{"ncbi_accession":["ERR12406007"],"spots":26031646,"bases":7861557092,"biosample":"SAMEA12111354","sra_experiment":"ERX11782058","sra_sample":"ERS9758186","sra_study":"ERP134027","study_name":"GunjurA_2024","sample_id":"GunjurA_2024_117","subject_id":"GunjurA_2024_117","treatments":"Nivolumab,Ipilimumab,Chemoradiotherapy","age":68,"sex":"Female","country":"Austalia","bmi":29.27,"ecog performance status":0,"subcohort":"GYN","curator":"Alice_Bassetto; Paolo_Manghi","westernized":"Yes","disease_response_recist":"RECIST Progressive Disease","disease_response_pfs_month":75,"disease_response_os_unit":"month","disease_response_os":187,"disease_response_pfs":"No","tumor_size_measurement":27.0,"location":"Melbourne","antibiotics_current_use":"No","dna_extraction_kit":"FastDNA","sequencing_platform":"NovaSeq","neutrophil_to_lymphocyte_ratio_measurement":5.33,"(uncurated)platelets":231,"albumin_in_g/dl":3.5,"lactate_dehydrogenase_measurement_in_u/l":243,"concentration":75.47,"number_bases":7861557092,"number_reads":52063292,"minimum_read_length":151,"median_read_length":151.0}
{"ncbi_accession":["ERR12405974"],"spots":28075306,"bases":8478742412,"biosample":"SAMEA12111306","sra_experiment":"ERX11782025","sra_sample":"ERS9758139","sra_study":"ERP134027","study_name":"GunjurA_2024","sample_id":"GunjurA_2024_84","subject_id":"GunjurA_2024_84","treatments":"Nivolumab,Ipilimumab","age":47,"sex":"Male","country":"Austalia","bmi":26.22,"ecog performance status":0,"subcohort":"UGB","curator":"Alice_Bassetto; Paolo_Manghi","westernized":"Yes","disease_response_recist":"RECIST Progressive Disease","disease_response_pfs_month":92,"disease_response_os_unit":"month","disease_response_os":118,"disease_response_pfs":"No","tumor_size_measurement":59.0,"location":"Melbourne","antibiotics_current_use":"No","dna_extraction_kit":"FastDNA","sequencing_platform":"NovaSeq","neutrophil_to_lymphocyte_ratio_measurement":2.83,"(uncurated)platelets":158,"albumin_in_g/dl":3.3,"lactate_dehydrogenase_measurement_in_u/l":165,"concentration":151.49,"number_bases":8478742412,"number_reads":56150612,"minimum_read_length":151,"median_read_length":151.0}
{"ncbi_accession":["ERR12405962"],"spots":18049189,"bases":5450855078,"biosample":"SAMEA12111293","sra_experiment":"ERX11782013","sra_sample":"ERS9758126","sra_study":"ERP134027","study_name":"GunjurA_2024","sample_id":"GunjurA_2024_72","subject_id":"GunjurA_2024_72","treatments":"Nivolumab,Ipilimumab,Proton Pump Inhibitor","age":42,"sex":"Female","country":"Austalia","bmi":19.13,"ecog performance status":0,"subcohort":"UGB","curator":"Alice_Bassetto; Paolo_Manghi","westernized":"Yes","disease_response_recist":"RECIST Partial Response","disease_response_pfs_month":1318,"disease_response_os_unit":"month","disease_response_os":1318,"disease_response_pfs":"Yes","tumor_size_measurement":83.0,"location":"Melbourne","antibiotics_current_use":"No","dna_extraction_kit":"FastDNA","sequencing_platform":"NovaSeq","neutrophil_to_lymphocyte_ratio_measurement":1.67,"(uncurated)platelets":353,"albumin_in_g/dl":3.7,"lactate_dehydrogenase_measurement_in_u/l":3435,"concentration":204.61,"number_bases":5450855078,"number_reads":36098378,"minimum_read_length":151,"median_read_length":151.0}
{"ncbi_accession":["ERR12405931"],"spots":21256871,"bases":6419575042,"biosample":"SAMEA12111336","sra_experiment":"ERX11781982","sra_sample":"ERS9758169","sra_study":"ERP134027","study_name":"GunjurA_2024","sample_id":"GunjurA_2024_24","subject_id":"GunjurA_2024_24","treatments":"Nivolumab,Ipilimumab,Chemoradiotherapy","age":72,"sex":"Male","country":"Austalia","bmi":24.08,"ecog performance status":1,"subcohort":"UGB","curator":"Alice_Bassetto; Paolo_Manghi","westernized":"Yes","disease_response_recist":"RECIST Stable Disease","disease_response_pfs_month":142,"disease_response_os_unit":"month","disease_response_os":160,"disease_response_pfs":"No","tumor_size_measurement":108.0,"location":"Melbourne","antibiotics_current_use":"No","dna_extraction_kit":"FastDNA","sequencing_platform":"NovaSeq","neutrophil_to_lymphocyte_ratio_measurement":3.65,"(uncurated)platelets":230,"albumin_in_g/dl":3.8,"lactate_dehydrogenase_measurement_in_u/l":208,"concentration":17.55,"number_bases":6419575042,"number_reads":42513742,"minimum_read_length":151,"median_read_length":151.0}
{"ncbi_accession":["ERR12405967"],"spots":21653660,"bases":6539405320,"biosample":"SAMEA12111300","sra_experiment":"ERX11782018","sra_sample":"ERS9758131","sra_study":"ERP134027","study_name":"GunjurA_2024","sample_id":"GunjurA_2024_77","subject_id":"GunjurA_2024_77","treatments":"Nivolumab,Ipilimumab,Chemoradiotherapy","age":51,"sex":"Female","country":"Austalia","bmi":21.93,"ecog performance status":0,"subcohort":"GYN","curator":"Alice_Bassetto; Paolo_Manghi","westernized":"Yes","disease_response_recist":"RECIST Partial Response","disease_response_pfs_month":368,"disease_response_os_unit":"month","disease_response_os":776,"disease_response_pfs":"No","tumor_size_measurement":54.0,"location":"Melbourne","antibiotics_current_use":"No","dna_extraction_kit":"FastDNA","sequencing_platform":"NovaSeq","neutrophil_to_lymphocyte_ratio_measurement":3.37,"(uncurated)platelets":275,"albumin_in_g/dl":3.6,"lactate_dehydrogenase_measurement_in_u/l":230,"concentration":66.37,"number_bases":6539405320,"number_reads":43307320,"minimum_read_length":151,"median_read_length":151.0}
{"ncbi_accession":["ERR12405909"],"spots":23091379,"bases":6973596458,"biosample":"SAMEA12111367","sra_experiment":"ERX11781960","sra_sample":"ERS9758200","sra_study":"ERP134027","study_name":"GunjurA_2024","sample_id":"GunjurA_2024_1","subject_id":"GunjurA_2024_1","treatments":"Nivolumab,Ipilimumab","age":70,"sex":"Female","country":"Austalia","bmi":30.73,"ecog performance status":1,"subcohort":"GYN","curator":"Alice_Bassetto; Paolo_Manghi","westernized":"Yes","disease_response_recist":"RECIST Progressive Disease","disease_response_pfs_month":78,"disease_response_os_unit":"month","disease_response_os":151,"disease_response_pfs":"No","tumor_size_measurement":55.0,"location":"Melbourne","antibiotics_current_use":"No","dna_extraction_kit":"FastDNA","sequencing_platform":"NovaSeq","neutrophil_to_lymphocyte_ratio_measurement":5.44,"(uncurated)platelets":227,"albumin_in_g/dl":2.8,"lactate_dehydrogenase_measurement_in_u/l":245,"concentration":110.89,"number_bases":6973596458,"number_reads":46182758,"minimum_read_length":151,"median_read_length":151.0}
{"ncbi_accession":["ERR12405995"],"spots":19363594,"bases":5847805388,"biosample":"SAMEA12111330","sra_experiment":"ERX11782046","sra_sample":"ERS9758164","sra_study":"ERP134027","study_name":"GunjurA_2024","sample_id":"GunjurA_2024_105","subject_id":"GunjurA_2024_105","treatments":"Nivolumab,Ipilimumab","age":72,"sex":"Female","country":"Austalia","bmi":20.53,"ecog performance status":1,"subcohort":"UGB","curator":"Alice_Bassetto; Paolo_Manghi","westernized":"Yes","disease_response_recist":"RECIST Progressive Disease","disease_response_pfs_month":45,"disease_response_os_unit":"month","disease_response_os":64,"disease_response_pfs":"No","tumor_size_measurement":30.0,"location":"Sydney","antibiotics_current_use":"No","dna_extraction_kit":"FastDNA","sequencing_platform":"NovaSeq","neutrophil_to_lymphocyte_ratio_measurement":10.67,"(uncurated)platelets":257,"albumin_in_g/dl":3.8,"lactate_dehydrogenase_measurement_in_u/l":194,"concentration":47.97,"number_bases":5847805388,"number_reads":38727188,"minimum_read_length":151,"median_read_length":151.0}
{"ncbi_accession":["ERR12405952"],"spots":20427761,"bases":6169183822,"biosample":"SAMEA12111277","sra_experiment":"ERX11782003","sra_sample":"ERS9758110","sra_study":"ERP134027","study_name":"GunjurA_2024","sample_id":"GunjurA_2024_62","subject_id":"GunjurA_2024_62","treatments":"Nivolumab,Ipilimumab","age":68,"sex":"Female","country":"Austalia","bmi":25.31,"ecog performance status":1,"subcohort":"NEN","curator":"Alice_Bassetto; Paolo_Manghi","westernized":"Yes","disease_response_recist":"RECIST Partial Response","disease_response_pfs_month":811,"disease_response_os_unit":"month","disease_response_os":1382,"disease_response_pfs":"No","tumor_size_measurement":76.0,"location":"Melbourne","antibiotics_current_use":"No","dna_extraction_kit":"FastDNA","sequencing_platform":"NovaSeq","neutrophil_to_lymphocyte_ratio_measurement":2.11,"(uncurated)platelets":400,"albumin_in_g/dl":3.6,"lactate_dehydrogenase_measurement_in_u/l":266,"concentration":68.92,"number_bases":6169183822,"number_reads":40855522,"minimum_read_length":151,"median_read_length":151.0}
{"ncbi_accession":["ERR12405976"],"spots":22289986,"bases":6731575772,"biosample":"SAMEA12111307","sra_experiment":"ERX11782027","sra_sample":"ERS9758140","sra_study":"ERP134027","study_name":"GunjurA_2024","sample_id":"GunjurA_2024_86","subject_id":"GunjurA_2024_86","treatments":"Nivolumab,Ipilimumab,Chemoradiotherapy","age":61,"sex":"Female","country":"Austalia","bmi":19.08,"ecog performance status":1,"subcohort":"NEN","curator":"Alice_Bassetto; Paolo_Manghi","westernized":"Yes","disease_response_recist":"RECIST Stable Disease","disease_response_pfs_month":168,"disease_response_os_unit":"month","disease_response_os":1088,"disease_response_pfs":"No","tumor_size_measurement":128.0,"location":"Melbourne","antibiotics_current_use":"No","dna_extraction_kit":"FastDNA","sequencing_platform":"NovaSeq","neutrophil_to_lymphocyte_ratio_measurement":1.71,"(uncurated)platelets":140,"albumin_in_g/dl":4.4,"lactate_dehydrogenase_measurement_in_u/l":186,"concentration":79.73,"number_bases":6731575772,"number_reads":44579972,"minimum_read_length":151,"median_read_length":151.0}
{"ncbi_accession":["ERR12405937"],"spots":17348241,"bases":5239168782,"biosample":"SAMEA12111341","sra_experiment":"ERX11781988","sra_sample":"ERS9758175","sra_study":"ERP134027","study_name":"GunjurA_2024","sample_id":"GunjurA_2024_35","subject_id":"GunjurA_2024_35","treatments":"Nivolumab,Ipilimumab,Proton Pump Inhibitor","age":73,"sex":"Female","country":"Austalia","bmi":23.47,"ecog performance status":1,"subcohort":"UGB","curator":"Alice_Bassetto; Paolo_Manghi","westernized":"Yes","disease_response_recist":"RECIST Progressive Disease","disease_response_pfs_month":37,"disease_response_os_unit":"month","disease_response_os":79,"disease_response_pfs":"No","tumor_size_measurement":27.0,"location":"Sydney","antibiotics_current_use":"No","dna_extraction_kit":"FastDNA","sequencing_platform":"NovaSeq","neutrophil_to_lymphocyte_ratio_measurement":1.39,"(uncurated)platelets":241,"albumin_in_g/dl":2.4,"lactate_dehydrogenase_measurement_in_u/l":240,"concentration":30.2,"number_bases":5239168782,"number_reads":34696482,"minimum_read_length":151,"median_read_length":151.0}
{"ncbi_accession":["ERR12405918"],"spots":22858385,"bases":6903232270,"biosample":"SAMEA12111370","sra_experiment":"ERX11781969","sra_sample":"ERS9758203","sra_study":"ERP134027","study_name":"GunjurA_2024","sample_id":"GunjurA_2024_10","subject_id":"GunjurA_2024_10","treatments":"Nivolumab,Ipilimumab","age":44,"sex":"Female","country":"Austalia","bmi":22.89,"ecog performance status":1,"subcohort":"GYN","curator":"Alice_Bassetto; Paolo_Manghi","westernized":"Yes","disease_response_recist":"RECIST Stable Disease","disease_response_pfs_month":308,"disease_response_os_unit":"month","disease_response_os":410,"disease_response_pfs":"No","tumor_size_measurement":38.0,"location":"Melbourne","antibiotics_current_use":"No","dna_extraction_kit":"FastDNA","sequencing_platform":"NovaSeq","neutrophil_to_lymphocyte_ratio_measurement":2.64,"(uncurated)platelets":166,"albumin_in_g/dl":4.1,"lactate_dehydrogenase_measurement_in_u/l":185,"concentration":41.86,"number_bases":6903232270,"number_reads":45716770,"minimum_read_length":151,"median_read_length":151.0}
{"ncbi_accession":["ERR12406011"],"spots":20348821,"bases":6145343942,"biosample":"SAMEA12111358","sra_experiment":"ERX11782062","sra_sample":"ERS9758191","sra_study":"ERP134027","study_name":"GunjurA_2024","sample_id":"GunjurA_2024_121","subject_id":"GunjurA_2024_121","treatments":"Nivolumab,Ipilimumab","age":57,"sex":"Male","country":"Austalia","bmi":29.68,"ecog performance status":1,"subcohort":"NEN","curator":"Alice_Bassetto; Paolo_Manghi","westernized":"Yes","disease_response_recist":"RECIST Stable Disease","disease_response_pfs_month":333,"disease_response_os_unit":"month","disease_response_os":671,"disease_response_pfs":"No","tumor_size_measurement":84.0,"location":"Melbourne","antibiotics_current_use":"Yes","dna_extraction_kit":"FastDNA","sequencing_platform":"NovaSeq","neutrophil_to_lymphocyte_ratio_measurement":4.31,"(uncurated)platelets":281,"albumin_in_g/dl":3.5,"lactate_dehydrogenase_measurement_in_u/l":301,"concentration":138.75,"number_bases":6145343942,"number_reads":40697642,"minimum_read_length":151,"median_read_length":151.0}
{"ncbi_accession":["ERR12405979"],"spots":18909533,"bases":5710678966,"biosample":"SAMEA12111311","sra_experiment":"ERX11782030","sra_sample":"ERS9758144","sra_study":"ERP134027","study_name":"GunjurA_2024","sample_id":"GunjurA_2024_89","subject_id":"GunjurA_2024_89","treatments":"Nivolumab,Ipilimumab","age":73,"sex":"Female","country":"Austalia","bmi":48.19,"ecog performance status":1,"subcohort":"NEN","curator":"Alice_Bassetto; Paolo_Manghi","westernized":"Yes","disease_response_recist":"RECIST Stable Disease","disease_response_pfs_month":290,"disease_response_os_unit":"month","disease_response_os":1227,"disease_response_pfs":"No","tumor_size_measurement":134.0,"location":"Melbourne","antibiotics_current_use":"No","dna_extraction_kit":"FastDNA","sequencing_platform":"NovaSeq","neutrophil_to_lymphocyte_ratio_measurement":2.81,"(uncurated)platelets":162,"albumin_in_g/dl":3.7,"lactate_dehydrogenase_measurement_in_u/l":311,"concentration":97.35,"number_bases":5710678966,"number_reads":37819066,"minimum_read_length":151,"median_read_length":151.0}
{"ncbi_accession":["ERR12405975"],"spots":21341238,"bases":6445053876,"biosample":"SAMEA12111308","sra_experiment":"ERX11782026","sra_sample":"ERS9758141","sra_study":"ERP134027","study_name":"GunjurA_2024","sample_id":"GunjurA_2024_85","subject_id":"GunjurA_2024_85","treatments":"Nivolumab,Ipilimumab","age":61,"sex":"Male","country":"Austalia","bmi":21.86,"ecog performance status":0,"subcohort":"UGB","curator":"Alice_Bassetto; Paolo_Manghi","westernized":"Yes","disease_response_recist":"RECIST Progressive Disease","disease_response_pfs_month":85,"disease_response_os_unit":"month","disease_response_os":607,"disease_response_pfs":"No","tumor_size_measurement":55.0,"location":"Melbourne","antibiotics_current_use":"No","dna_extraction_kit":"FastDNA","sequencing_platform":"NovaSeq","neutrophil_to_lymphocyte_ratio_measurement":3.55,"(uncurated)platelets":133,"albumin_in_g/dl":3.8,"lactate_dehydrogenase_measurement_in_u/l":261,"concentration":52.8,"number_bases":6445053876,"number_reads":42682476,"minimum_read_length":151,"median_read_length":151.0}
{"ncbi_accession":["ERR12405957"],"spots":30047441,"bases":9074327182,"biosample":"SAMEA12111286","sra_experiment":"ERX11782008","sra_sample":"ERS9758119","sra_study":"ERP134027","study_name":"GunjurA_2024","sample_id":"GunjurA_2024_67","subject_id":"GunjurA_2024_67","treatments":"Nivolumab,Ipilimumab","age":63,"sex":"Female","country":"Austalia","bmi":20.55,"ecog performance status":1,"subcohort":"UGB","curator":"Alice_Bassetto; Paolo_Manghi","westernized":"Yes","disease_response_recist":"RECIST Partial Response","disease_response_pfs_month":410,"disease_response_os_unit":"month","disease_response_os":530,"disease_response_pfs":"No","tumor_size_measurement":61.0,"location":"Melbourne","antibiotics_current_use":"No","dna_extraction_kit":"FastDNA","sequencing_platform":"NovaSeq","neutrophil_to_lymphocyte_ratio_measurement":9.8,"(uncurated)platelets":244,"albumin_in_g/dl":2.9,"lactate_dehydrogenase_measurement_in_u/l":211,"concentration":131.8,"number_bases":9074327182,"number_reads":60094882,"minimum_read_length":151,"median_read_length":151.0}
{"ncbi_accession":["ERR12405972"],"spots":23501023,"bases":7097308946,"biosample":"SAMEA12111303","sra_experiment":"ERX11782023","sra_sample":"ERS9758137","sra_study":"ERP134027","study_name":"GunjurA_2024","sample_id":"GunjurA_2024_82","subject_id":"GunjurA_2024_82","treatments":"Nivolumab,Ipilimumab,Proton Pump Inhibitor,Chemoradiotherapy","age":59,"sex":"Male","country":"Austalia","bmi":23.65,"ecog performance status":1,"subcohort":"NEN","curator":"Alice_Bassetto; Paolo_Manghi","westernized":"Yes","disease_response_recist":"RECIST Stable Disease","disease_response_pfs_month":167,"disease_response_os_unit":"month","disease_response_os":1182,"disease_response_pfs":"No","tumor_size_measurement":22.0,"location":"Melbourne","antibiotics_current_use":"No","dna_extraction_kit":"FastDNA","sequencing_platform":"NovaSeq","neutrophil_to_lymphocyte_ratio_measurement":2.78,"(uncurated)platelets":168,"albumin_in_g/dl":3.5,"lactate_dehydrogenase_measurement_in_u/l":192,"concentration":110.96,"number_bases":7097308946,"number_reads":47002046,"minimum_read_length":151,"median_read_length":151.0}
{"ncbi_accession":["ERR12406004"],"spots":21778904,"bases":6577229008,"biosample":"SAMEA12111350","sra_experiment":"ERX11782055","sra_sample":"ERS9758182","sra_study":"ERP134027","study_name":"GunjurA_2024","sample_id":"GunjurA_2024_114","subject_id":"GunjurA_2024_114","treatments":"Nivolumab,Ipilimumab,Proton Pump Inhibitor","age":76,"sex":"Female","country":"Austalia","bmi":27.18,"ecog performance status":1,"subcohort":"UGB","curator":"Alice_Bassetto; Paolo_Manghi","westernized":"Yes","disease_response_recist":"RECIST Stable Disease","disease_response_pfs_month":58,"disease_response_os_unit":"month","disease_response_os":330,"disease_response_pfs":"No","tumor_size_measurement":50.0,"location":"Albury","antibiotics_current_use":"Yes","dna_extraction_kit":"FastDNA","sequencing_platform":"NovaSeq","neutrophil_to_lymphocyte_ratio_measurement":1.61,"(uncurated)platelets":130,"albumin_in_g/dl":3.8,"lactate_dehydrogenase_measurement_in_u/l":445,"concentration":51.39,"number_bases":6577229008,"number_reads":43557808,"minimum_read_length":151,"median_read_length":151.0}
